CA2080022C - Implantable glucose sensor - Google Patents
Implantable glucose sensorInfo
- Publication number
- CA2080022C CA2080022C CA002080022A CA2080022A CA2080022C CA 2080022 C CA2080022 C CA 2080022C CA 002080022 A CA002080022 A CA 002080022A CA 2080022 A CA2080022 A CA 2080022A CA 2080022 C CA2080022 C CA 2080022C
- Authority
- CA
- Canada
- Prior art keywords
- sensor
- electrode
- enzyme
- indicating
- membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
- C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6848—Needles
Abstract
Implantable enzymatic sensors (25, 43, 44) for biochemicals such as glucose are provided having an ideal size and geometry for optional long term implantation and linear responses over the concentration ranges of interest. The sensors (25, 43, 44) include an elongated body (10, 26, 46) supporting an indicating electrode section having an appropriate enzyme immobilized thereon to present an enzymatic indicating surface (21, 33, 54). A permeable synthetic polymer membrane (24, 42, 56) is applied over the sensor body (10, 26, 46) to protect the enzyme and regulate diffusion of analyte therethrough, to ensure linearity of sensor response. The sensors (25, 43) are of flexible design and can be implanted using a catheter. Alternately, the sensor (44) includes an internal indicating electrode body (46) housed within an apertured, hollow needle (48). A holder (66) affixed to the needle (48) allows for easy manipulation and implantation of the sensor (44).
Description
wO 91/15993 PCI/US91/02641 IMPLANTABLE GLUCOSE SENSOR
This is a Continuation-ln-Part of Application S/N 07'511.059. filed April 19. 1990 Back~round o~ the Invention a 1. Field of the Invenlion The present invention is broadly concerned with a subcutane-ously implantable enzymatic sensor charac~erized by small size. oplimum geometry and linearity oE sensor response over the concentration range of interest. More particularlv. it is preferablv concerned with an imFl~nt~hle glucose sensor oE this type designed ~o p~ovide, in conju~,lion with a suitable signal processing unil. a currenl which is propor~ional ~o subcutaneous glucose concentration. In preferred forrns. glucose sensors of the inven~ion are based on the en_yme-cataly_ed oxidation of glucose ~o gluconic acid and hydrogen peroxide, ~he latter being moni~ored a~ e,o,l.c~rically by the sensors.
This is a Continuation-ln-Part of Application S/N 07'511.059. filed April 19. 1990 Back~round o~ the Invention a 1. Field of the Invenlion The present invention is broadly concerned with a subcutane-ously implantable enzymatic sensor charac~erized by small size. oplimum geometry and linearity oE sensor response over the concentration range of interest. More particularlv. it is preferablv concerned with an imFl~nt~hle glucose sensor oE this type designed ~o p~ovide, in conju~,lion with a suitable signal processing unil. a currenl which is propor~ional ~o subcutaneous glucose concentration. In preferred forrns. glucose sensors of the inven~ion are based on the en_yme-cataly_ed oxidation of glucose ~o gluconic acid and hydrogen peroxide, ~he latter being moni~ored a~ e,o,l.c~rically by the sensors.
2 D~~ ion of ~he Prior Art There have been a great many a~tempts in the past to develop t~iable rl_J~?~'~ sensors for ~.,Lin,lous in vivo ~ ,asu.~,...en~s of bio, h~...;-cals. For example. conside.àblc effort has been made to devise reliable implantable sensors ~or ,..onito,i..g glucose concen~.dtions in blood. Such determin~fior~c are useful in a variety of applications, e.g., in the ~.~,.. ;.. ~"t of irc One difficulty in pl~ ing a reliable ~ nt;-l''S glucose sensor is that glucose levels in the bloo bllcal.. of a patient vary on a time basis and are normally ~ pe ~d ~ upon the physical activity oE the individual. his food, beverage and sugar intake. his m~t~bolir ra~e, and o~her ind;~ i7Pd fac~ors.
Furthermore, the geo....... ,l.~ of the sensor must be such as ~o adapt to implanta-fion in a living patient.
Glucose sensors have been p.ul osed in ~he past which rely upon the well-r~ctablichr~d enzyme-catalyzed ~Yi.1~tic n oE glucose wherein glucose and oxygen function a. substrates ~or the enzyme glucose oxidase in the production of gluconic acid and hydrogen peroxide, ~he latter being l.. o-.ito.cd ampero-metrically. See, for example, U.S. Patents No. 3,539,455 to Clark and 4.671.288 ~ to Gough.
Although the idea of an imrl~n--\-'s ellL~IIId~iC glucose sensor is not ~ new, cor~iderab'~ difficulty has been el.co~,nte,~d in p~udu~hlg reliable.
cost-efficient devices o~ this character. For ~Y~ , many p.opos~ sensor . ~
' . ' .;. . ~ . . .
. ~
Furthermore, the geo....... ,l.~ of the sensor must be such as ~o adapt to implanta-fion in a living patient.
Glucose sensors have been p.ul osed in ~he past which rely upon the well-r~ctablichr~d enzyme-catalyzed ~Yi.1~tic n oE glucose wherein glucose and oxygen function a. substrates ~or the enzyme glucose oxidase in the production of gluconic acid and hydrogen peroxide, ~he latter being l.. o-.ito.cd ampero-metrically. See, for example, U.S. Patents No. 3,539,455 to Clark and 4.671.288 ~ to Gough.
Although the idea of an imrl~n--\-'s ellL~IIId~iC glucose sensor is not ~ new, cor~iderab'~ difficulty has been el.co~,nte,~d in p~udu~hlg reliable.
cost-efficient devices o~ this character. For ~Y~ , many p.opos~ sensor . ~
' . ' .;. . ~ . . .
. ~
3 Pcl/US91/o2641 2 ~ 8 ~ 0 2 2 geometries are simply not re~lictic~lly implantable. at least for the periods of time required for adequate clinical glucose monitoring. Thus, the devices proposed in the '288 Gough Patent, because of a requirement of multiple elec-trodes carried within a tubular needle, inevitably are of such diameter as to beS uncomfortable to the user and not practical for extended iml l~nt~tion.
Furthermore, many prior sensors do not exhibit a stable and linear response, particularly over PYt~nAed times of impl~nt~tinn, and do not give accurate and reliable results. Finally, fa~.icaLioll of prior glucose sensors has presented formidable difficulties, to the extent that only about one in five sensors pro-duced by ~,on~cnlional te.,l.n;~ues are deemed usable. This obviously repre-sents a considerable inefficiency, to the point that no truly successful implant-able glucose sensor has helel~role been p.uduced on a large scale.
Summar~ of the Invention The present invention o~e.~lllLs the plùbl_...s outlined above, and 1~ provides a greatly i--.~J~u.ed ~,.l~lllal;c sensor specifically designed for long-term impl~nt~tinn in a patient. The sensor is adapted Eor pncitinning in an em,hc l".,cnt characterized by the presence of biological mr~ ec which are substrates for or products y~os~uc~d by enzymes, in order to d~rmin~ the presence of such biological molecules. While the p.h~ci~lcs of the invention may be used in the fabrication of glucose sensors, the invention is not so limited. Indeed. the sensors in a~u,dancc with the invention may be produced using a wide variety of h..-..obil;~d enzymes. for the detection of an equally large number of analytes. Exemplary enzymes and their cullc~yonding sub-strates are given in U.S. Patent No. 4,721,677 to Clark, and this patent is incorporated by reference herein.
In any event, the enzymatic sensors in accordance with the invention preferably are in the form of an elongated body supporting at least an indicat-ing electrode, with the inrlir~ing electrode presenting a seclion adapted for exposure to the biological environment. The inr~ir~inv electrode section has an enzyme operably immobilized thereon to present an enzymatic inrlir~ing surface. A number of variants are possible for the reference electrode. For PY~m?la~ use may be made of an exteïlialiy applied eleciiocd~diog~ai" ~ic;"
electrode (an 8 mm disk covered with silver chloride and available as Model E-24~ frûm the Phymep Company, 21 Rue Campoformio, Paris, France)~ or a reference electrode which is implanted with the in(licating electrode.
WO 91/15993 PCl/US91/02641 3, 2080022 In one specific embodiment employing an implanted reference elec-trode, the indicating surface oE the irl-iir~ting electrode and the reference elec-trode are laterally spaced apart along the length of the body and each substan-tially ~h~,ulll~libes the latter and is sllhs~:lnti~lly exposed to the biological environment when the sensor is placed therein. Use oE such circumferentially f Ytentling enz~matic in~irating surfaces and reference electrodes sections is believed to be an important aspect of this embodiment. Alternately, the reference electrode section may c~ ..ise a CUIJdU~ Ve salt bridge ~ .Ulll~
ing the body and Iying in a plane transverse to the lon~itl.-iin~l axis of the body; in this case, a lcr~,~cnce electrode is placed in electrical contact with the salt bridge, through use oE a buffered electrolvte. In another embodiment, the reference electrode is simply placed adjacent the inrlirating electrode as a part of the overall sensor.
In preferred practice, the sensor body advantageously comprises an f 1~ lly COf~lu Li-,e noble metal ~e ~ pla~num or ~ iridium) electrode covered with electrically insulative material. with a portion of this material removed from the ele~ ,dc to define an enzyme--ccelvil~g zone. Thus, a short length of Teflon (polytetrafluoroethylene) coated platinum-iridium wire may be provided, with a short section of the inclll~tion removed intermediate the ends of the wire, so that respective segmt ntC of the incul~ting material are on opposite sides of and define a recessed enzyme-receiving .,i~culllfe~c.~lial zone.
Alternately, the endmost portion of the Teflon may be removed, leaving a protruding exposed stretch of wire which defines the enzyme-receiving zone.
An enzyme is operably immobilized on the exposed section of the platinum-iridium wire~ by known means such as adsorption of the enzyme on a cellulose acetate or Nafion layer (1-3 microns thirL-nf~cc), followed by cross linking with giutaraldehyde.
Another important aspect of the present in-ention resides in the preferred use of a synthetic polymer membrane disposed over the enzymatic in(iic~ting surEace to serve as a permeable protective layer. In particular. a layer of polyurethane is advantageously applied as a thin coating over at least thc inr~ ng su.facc (and ;;._.~ra'lj- thc clliirc inr1icat;np electroLlc) hi oruc~
to protect the el"yll~atic reaction surface from the biological environment.
Moreover, this layer provides a diffusional barrier Eor glucose which slows down3~ the flow of glucose and creates a linear sensor response over the concentration Wo 91/15993 PcltUS9l/o264 2 0 8 0 ~ 2 2 ranges of interest. In particular, in order to achieve the desired linear re-sponse, use is made of an active enzyme layer and a relatively thin protective membrane. It is important that the membrane regulate the passage of mole-cules therethrough to an extent that the enzymatic reaction between the in-iirating sur&ce and these molecules is determined by the rate of diffusion through the Illu~llblanC, and not the en_ymatic reaction kinetics. In practice using the methods of sensor construction herein described, an optimal balance between the ~ el;~& goals of linear response and se.~ ivily and response times may be achieved.
The use of an ad~ ;n~ negatively charged inner l"~,.. ,b,~.ne layer immlorliately adjacent the Pt-lr wire also retards the diffusion of negatively charged species (e.g. ascorbate and urate) in the biological e..vi.olll..-,..t which are interfering species. Of course, this inner ~ .,.b~dne does not cignifir~ntlyexclude hydrogen peroYide, an electrically neutral species.
Although the l1.~ ~ of the o~ l pol~e~l~an~ ' .......... ne has not been spe~ifir~lly ascertained, it is ~ctim~ted that the membrane has a of from about 5 to 10 microns in the p~f~ ;d glucose sensors hereof.
The sensors described above are, by virtue of their construction, relatively fleYible and therefore comfortable in use. However, this same cll&~ liaLic Ele,Yibility makes it nccessa,y to employ a catheter to implant thesensors. In an alternative embodi".~nt, sensors may be provided which can be readily implanted without the need of a catheter, even by the patient himself.
In such embodiments, use is made of an Plong~t~l tubular, metallic housing, typically a conventional hypodermic needle; the sensor apparatus is inserted within the needle, and includes an inrlirating electrode having a section thereof provided with immnbili7.od en_yme. In order to expose the en_yme to the biological environment, the needle sidewall is apertured in registry with the en_yme. A holder is also provided adjacent the rearward end of the needle body in order to facilitate manipulation and insertion of the sensor. This holder advantageously is in the form of a transversely PYtPn~ling flag-like plastic bv '; ..ccu,~d to the needle housing.
The invention also collll),ehel,da a novel method of applying the polyurethane membrane described previously. That is to say, a real difficulty inthe production of enzymatic sensors stems from the difficulty of applying .
WO 91/15993 PCl/US91/02641 2~8~022 various materials uniformly to a very small, implantable device. rnis difficultyhas been overcome in the context of the present invention, by applying to the sensor surface a well-defined volume of a polymer dissolved in an organic solvent such that lhe film is unitormly distributed across the surface. In S practice, this method is carried ou~ by providing a wire loop, and holding the coating liquid in the loop by sur&ce tension to form the desired polymer solu-tion droplet, followed by passing the electrodes through the loop to achieve uniform coating along the length of the sensor body.
The enzymatic sensors of the invention have an ideal geometry for imp!~ a~jon Generally spe~kingl the flexible units not housed within a needle are equivalenl in size and shape to a 26-gauge needle (i.e., about 0.45 mm.
oulside diameter). Moreover, ~heir geometry perrnits the reproducible deposi-tion of films and materials and allo vs careful control of the amount and orien~tinn of the enzyme onto the in~ a~ing electrode. hnally, the preferred ser~sors are e~f~Li~ "capped~ with ;~ n~~ (Te~n) which ~revents the sensors from penetrating further into the tissue than is required. Thus. the h~ ion of the sensor causes minimal trauma to the tissue and to the sensor itsel~ The sensor can flex laterally, and this again ...i~ tissue damage caused by movement of the patient.
In the case of implantable glucose sensors, response times of less than two minutes and linearities over glucose concc,nt~ations of 0-25 mM can be achieved. At the same time, through use of the fabrication ~C~ l~n;~lUf ~ of theinvention, the rejection rate upon initial m~nuf~t~lre is drastically reduced.
In the case of sensors received within a needle housing, such can be readily manipulated by the patient for implantation pUIl~OSCS. These sensors typically have a slightly larger diameter than the flexible sensors described previously, but are not so large as to cause ~ ;cco...folL. This relative-ly small size is assured because of the sensor construction, making use of a small Teflon-coated Pt-Ir wire and immobilized enzyme.
Brief De~iv ~c of the Druwin~s Figure I is an enlarged, sectional view illustrating a glucose sensor in accord~ncc; wiil~ e inv~nli~n;
Fig. 2 is an enlarged, sectif n~l view o~ another glucose sensor in accordance with the invention;
:' , .
, i, :, .. . . ~
WO 91/15993 PCI~/US91/02641 2 0 8 0 ~ 2 2 Fig. 3 is a graph showing the linear sensor response of the Fig. 1 glucose sensor over a glucose Col1CC~llrdtiOn range of 0-25 mM;
Fig. 4 is a graph illustrating the storage stability of the Fig. 1 glucose sensor;
Fig. 5 is a sectional view depicting another sensor embodiment wherein the inllicating electrode is housed within an impl~nt~hle needle:
Fig. 6 is a perspective view of the sensor illustrated in Fig. 5; and Fig. 7 is a p.,.S,~,~.,livc view of an emho~limpnt similar to that of Fig. 6.
but depicting the use of an implantable reference electrode.
D~ t- of the ~lef~ A ~,d F
The following ~.dlllples illustrate the construction of glucose sensors depicted in Figs. 1 and 2~ and are d~crrihed with particular ~c;Lelt,nce to the,se drawings. It will be understood. however, that the .oY~mplP5 are illustrative only, and nothing therein,should be taken as the limit~ti~n UpOli the overall scope of the i~.. ~
Example 1 - Fi~. 1 One end of a 10 cm section 10 of Medwire Co"~o~ation Teflon-Coated platinum-iridium wire is provided. The section 10 includes a central pl~tinllm_ iridium wire 12 (0.18 mm o.d.) and a coating of insulative Teflon 14 (0.035 mm shirlrnPc~) the.Garou"d. The central wire 12 forms the int~ir~ting electrode from the sensor. A cavity 16 (1-3 mm in length) is formed in the wire 10 as shown in Fig. 1. This is achieved by first putting a circular cut on the Teflon coating with a paper cutter and then pulling the Teflon out to create a cavity of about 1 millimf~ter in length, exposing a corr~pQn~ling section of the wire 12. The excess Teflon extending beyond the left end of the wire 12 is then trimmed off with the cutter.
The ~ ce electrode 18 is formed on the Teflon surface, about I.5 millim.oters to the right of thé exposed platinum iridium surface as viewed in Fig. 1. A thin silver wire (0.1 mm o.d., 15 cm length) is tightly wrapped aroundthe teflon surface covering to form a coil 20 of about 5 millimt~t.ors in length.
A wire wldpping tool may be utilized for this purpose. The trailing portion of the wirc ;u ih ;; liglli Or coil 20 i~ /VCICl wiin a section 22 of heal shriJI~cabi~
Teflon tubing (5 cm long, 1.5 mm o.d., Zeuss Industrial Products Inc.), leaving small lengths of the silver wire and platinum iridium wires uncovered to serve as electrical leads. A heat gun operating at 600~C is employed for shrinking , .
:. :
.
WO 9l/15993 PCltUS91/02641 -7- 2~0022 !j . '.j.
the Teflon tubing. A layer of silver chloride is formed on the coil 20 by passing current (0.4 mAlcm2) for 60 minutes through the wrapped silver wire while it is dipped in a stirred ().1 N HCL solution. The exposed por~ions of reterence electrode 18 are then rinsed with de-ionized water for 6 hours. The reference electrodes plepaled in this manner show a potential of -64 + 3 mV
(n=10) vs. Ag/AgCl(3M NaCl) in 0.15 M NaCl at 370C.
In order to immobilize glucose oxidase (GOx, E.C.1.1.3.4) on the exposed portion of wire 12, an inner, negatively charged l~ lblane is first applied to the exposed wire section. Thereaher. a circumferentially ~Y~.on~ling erlzymatic inrli~,q.~ing layer 21 is formed within cavity 16. Two different ap-plUd~,ll(.,S have been employed to achieve these ends.
Attqrhm~nt of GOx to bovine serum albumin coupled cellulose acetate The exposed platinum iridium surface within cavity 16 is degreased by washing with acetone. It is then rinsed with de-ionized water and dried in cold air stream before polymer deposition.
The left hand part of the sensor (portion to the left of the ~ ,nce electrode coil 20) is dipped into 5% cellulose acetate (39.8% acetyl content) inSO~o acetone and 50% ethanol for 10 seconds and is withdrawn slowly. It is 2~ then exposed to the vapor above the cellulose acetate solution for 5 seco.. ds and is dipped again into the cellulose acetate solution for 10 seconds. The sensor is then removed and dried in air at room temperature (230C) for one minute and placed in d.,;olliGed water for 6 hours to permit disp!qrPm~n~ by water of entrapped solvent in the llle.llbldne pores. The cellulose acetate Ill~lllI"dnc prepared in this fashion shows good long-term stability and also discriminates well against ascorbate and urate. Bovine serum albumin (BSA) is then covalently coupled to cellulose acetate and a subsequent reaction of the membrane with GOx~ which has previously been activated with an excess of p-benzoquinone, is carried oul. The detailed procedure for this reaction is described in the literature, Sternberg et. al.. Anal. Chem. 1988, 60~ 2781. which is incorporated herein by reference.
B. Physical adsorption of enzvme on cellulose acetate or Nafion followed by crocclinking with glutaraldehvde 1. The sensor is coated with cellulose acetate in exactly the same manner as described above to create membrane. The GOx (270 U/mg) is - . .
WO 91/15993 Pcr/US9l/o26 2 0 ~ O ~ 2 2 physically adsorbed by dropping 5 Ill of GOx solution (40 mg/Ml in 0.1M
phosphate buffered saline) on the in~lira~ing element within cavity 16, and is allowed to dry for 10 minu~es at room temperature. To immobilize the enzyme and form circumferential surface 21, the sensor is exposed to glutaraldehyde vapor generated from 25% glutaraldehyde solution placed at the bottom of an enclosed glass chamber for 12 hours at room temperature. The sensor is then rinsed in de-ioni~d water and dried in air for 2 hours. The croc~1inlcing with glutaraldehyde protects the enzyme from heat degradation, proteolytic enymes and hydrolysis, E.M. Salona. C. Saronio. and S. Garattini (eds), "Insolubilized Enz3nnes." Raven, New York, 1974, ;ncc"~uldted by rcfe.c.,~ herein.
2. Nafion (Perfluorosulfonic acid poly-mer. obtained from E.I. DuPont de Nemours and Co., m~ay~also be used as an ~Itlorn~e fûr cellulose acetale for the inner membrane. After cleaning the sensing portion of the sensor as above, it is electrocoated with Nafion using the method described by Adams e al, Neurosci. Meth VoL 2Z, I987, pp 167-172, illw~la~ by ,er~.~.. ~
herein. One drop of Nafion (5% solution, Aldrich) is placed in a 2 mm loop formed at one end of a copper wire. A DC potential of +3V is applied to the working electrode with respect to the loop for 10 seconds. The sensor is pulled out of the loop before turning off the potential and is dried in air for 2 hours, and the GOx enzyme is applied as described above.
Alternate polymers may be used in lieu of or in combination with cellulose acetate or Nafion for coating of the exposed Pt-Ir wire surface. For example, polyaniline and poly-phenol derivatives can be electroçhemir~lly deposited onto the exposed in~lira~ing electrode surface. Oxidative electro-polymerization of aniline and phenol monomer yields stable and adhesive coating over the exposed wire. These materials moreover have good size selec-tivity which can be utilized to further improve the sensor sele~,livily against electroch.ornir~l inte,~lences in biological envi.ollll.en~. The combination of a size selective coating with a charge selective film (e.g. cellulose acetate) mayreduce the in ~ivo background current and the risk of electroch~mic~l interfer-ence. Electropolymerization ot aniline and phenol is well known, see for exam?le Chsalca ei al. ~lal. Chelll. 19~7, J9, i7~ô-oi, ~nd ivia;;~ L~ e~ ai.
Anal. Chem. l990, 62, 2735-40, both of which are incorporated by reference herein.
.
:
9 20~0~22 Finally; Eastman-Kodak AQ 29-D polymer (poly (ester-sulfonic acid)) has both charge and size selective features, and may be applied ~o the exposed indicating electrode wire in lieu of Nafion. A coating of this type applied to the indicating electrode with a cellulose acetate layer thereover should improveoverall selectivity. Combined coatings made from miAtures of cellulose acetate and the AQ 29-D polymer should also provide advantages in terms of sensor selectivity.
In order to cc F'. e the plepala~ion of the sensor, the whole assembly, including the reference electrode~ is dip coated with 4% polyurethane (Thermedics, SG ~5A) dissolved in 98% tetrahydrofuran (l~ ) and 2%
dimethylformamide (DM~;) to form an outer membrane 24. The polyurethane solution (I0 uL) is held in a wire loop (2 mm i.d.) by surface tension and the sensor is passed through the loop. This leaves a uniform polymer film on the col p'cted sensor 25 to the api!.uy~ate extent depicted in Fig. I. This method l; provides a good control over Ihe arnount of po~rmer which is applied to the sensor. The sensor is dried in air for 6 hours at room temperature and then left in 0.I M i hosph~te buffered saline, pH=7.4 for 72 hours for the various outer membranes to co~ n fully. It is possible to recoat the sensor with polyurethane if the desired linear range of glucose sensitivity is not obtained after the first coating.
EAample 2 - Fii-~. 2 One end of a 10 cm section 26 of Teflon-coated platinum-iridium wire is provided having a 0.I8 mm o.d., a central Pt-Ir wire 28 and a teflon sheath 30 (0.035 mm thi~-lrnl-cs). The left hand end of the wire is stripped to form a ~ - .
cavity 32 as described in EAample I. The right hand end of section 26 is then inserted into a 5 c~ ntimf ~ers long polyethylene tube 34 (0.67 mm o.d., 0.30 mmi.d.). The left hand /_Alre.lli~y of the polyethylene tube is sealed by putting a drop of 4% cellulose acetate solution (in acetone)into the opening. The acetone is allowed to dry while holding the Tefion-coated wire in the middle of the polyethylene tube. This permits ~he formation of a circumferential salt bridge deposit 36 which effectively acts as the terminal part of the reference ciec~rodc, iics in ~ plane tran~ver~e ~ ~h~ ngitu~iin~i axis of the wire ~ anci establishes electrical contact between the reference and sensing electrodes.
The empty annular space between the Teflon-coated wire and the polyethylene tube is then filled under vacuum with 0.1 M phosph ~P buffer, pH = 7.4 con-.
' ' : : : ' ' : : :
- : :
- . . ., ~
Wo 91/15993 PCI/US9t/02641 2080~22 -10- ~
- taining 9 glL NaCI. A chloridized silver wire 38 (0.05 mm o.d. 5 cm long prepared as described in Example 1) is introduced inlo Ihe polyethylene tube Erom the righ~ hand end ~hereof and ~his opening is also sealed as described above ~o presen~ a sealing deposit 40. The reterence electrode shows a S potential of -60 + 10 mV (n=6) vs Ag/AgCI (saturated KCL) a~ 370C. The enzyme immobilization and polyurethane deposition steps are then carried out using the p~u._elulcs described in Example 1 to give the inner negatively charged Illclllblane 32a the u h- u~fe~ential in~ir~ing enyme layer 33 and outer permeable luclllb,dne 42 illustrated in Fig. ~. The complete sensor 43 is then ready for calibration and use with electrical ronn~l;o.~ afforded by the aYially ~Yten~ing ends oE the wires 28 38.
The sensors described in the above example are calibrated by dipping into a thermnsrAted cell (aL 370C) con~aining 10 ml of stirred 0.1 M phosphate buffered saline pH = 7.4 and a potential of +600 mV (for hydrogen peroxide leteetir~n) is applied between the work;ing and the . f .ence~ ; e elec-trodes. The background current is allowed to stabilize for 20 minutes. The calibration of the sensor is carried out by adding increasing amounts of glucose~o the stirred buffer. The current is measured at the plateau (steady state response) and is related to the concel ll~tion of the analyte. Following the calibration procedure the sensors are stored in 0.1 M phosphate buffered saline pH = 7.4 at room temperature.
A typical response curve to the glucose addition is shown in Figure 3 for a sensor made in accordance with Fig. 1. As illustrated. the response characteristics of the sensor over the concentration range of interest (0-25 mM) are essentially linear. and are especially so over the range oE 0-15 mM.
The sensor oulput is also essentially independent oE the stirring rate. The in vitro characteristics of the sensor are sullllll .li~ed in the following Table. A
typical storage stability cur~e for the sensor is shown in Figure 4. During the first few days of sensor preparation the polyurethane membrane changes its permeability for glucose as a result of hydrolytic and swelling processes. Ieading to the increased passage of glucose and an increased curren~. After this initialCliGu, L~/Wt;~c;r, ~h~ stability is f YrellPni The sensors of the invention are in use electrically coupled with suitable signal processing e~uipment. and implanted into a desired sl-hcl-~ne-ous site. Glucose and oY~ygen diffusing ~hrough ~he ou~er synthetic polymer .
..
' :
Wo 91/15993 PCl/US91J026~
2 ~ 2 2 l~ ~
membrane are enzymatically catalyzed by the GOX at the in~jca~ing surEace, resulting in production of gluconic acid and hydrogen peroxide. The latter is measured amperometrically, which is a measuremenl ol glucose concentration.
TABLE
In Vitro Characteristics of Fig. 1 Glucose Sensor Parameter Value Residual current (nA~mm~)a 0.7 + 0.2 Sensitivity (nA/mM mm2) 1.~ + O.g Linear Range (upper limit) (mM) 15 ~ 3 Response time (min.), T 90% 3.5 ~ 1 .. ..
Results shown above are expressed as mean + SD for six sensors.
a Residual currents are ll,ca~ul~:d after 1 hour of polarization.
Figs. 5 and 6 illustrate another sensor 44 in accordance with the invention. In this case, the sensor body 46 is received within a stainless steelhollow tubular needle 48.
The sensor body 46 includes an innermost~ Tetlon-coated, pla~inum-iridium wire 50 (90% Pt/10% Ir) having a total O.D. of about 0.2 mm and a cavity 52 formed therein as described in Example 1. The cavity 52 is approxi-mately 1.0 mm in length and is located about 3.0 mm from the tip of the wire 50. A glucose oxidase layer 54 is immobilized within the cavity 52. and com-prises a cellulose acetate polymer layer attached to the surface of the Pt-Ir wire, wilh g,ll~;o~c u)dd~ rl~cciin;cpd thl.Ju~ iuiaraid~hydt: unlu iht:: ceiluiose acetate. This procedure is in acco..lancc with Example 1.B.1. above. The en-tirety of the in~ira~ing electrode is then covered by a membrane 56 oE polyure-thane, again using the method set forth in Example 1.
. .: ~ . ' . :' ' .
... ,. . ~.: - . :-2 0 8 a o 2 2 The sensor body 46 is thereupon inserted into a 25-gauge disposable r - stainless steel hypodermic needle, the latter having an aperture 58 adjacent the l'orward~ sharpened insertion end 60 thereof. The sensor body 46 is installed insuch manner that the glucose oxidase layer 54 comes into registry with the sidewall opening 58, thereby exposing the layer 54 to the biological environ-ment. A silicone rubber plug 62 is installed in the forward end of the needle 48 as shown.
As illustrated in Fig. ~, the wire 50 extends rearwardly out of the end of needle 48, and is adapted to be connected with appropriate instrumenlation ~or I0 measuring glucose conce,.L~atiol1s. In order to seal the rearward end of the sensor 44. a bead 64 of epoxy is applied around the wire 50 and the butt end of the needle 48 and sensor body 46.
The overall sensor 44 is completed by provision of a holder 66 extend-ing transversely of the needle 48. The holder 66 is preferably in the form of a plastic sheet wrapped around the rearward end of the needle 4~ as shown. and secured by means of epoxy or polycyanoacrylate glue. The holder 66 permits ready manipulation and insertion of the sensor 44 even by the patient.
In the use of sensor 44, the reference electrode may be either external-ly applied or implanted. As an external electrode, use may be made of a commercial ele~lu~aldiogram skin electrode described previously may be used.
An external reference electrode should be applied in close plu~dl~ y to the impl~nted sensor for the best measurement results. The holder 66 may also be used to support an external electrode of the type described previously. Inas-much as the holder lies closely adjacent the skin upon implantation, the holder may serve as an ideal platform for the external electrode.
Fig, 7 illustrates an embodiment wherein use is made of an implantable reference electrode. In this case, the needle 48 has an electrodepoci~Pd layer 68 of silver on the external surface thereof, with this layer being ;lnotli7Pd in the presence of chloride ion to create a Ag/AgCI reference electrode. A silver lead wire 70 is conductively affLxed to the rearward end of needle 48 by means of silver epoxy or similar expedient, and the holder 66 is wrapped about this conneciior. aS ;.how.l.
Alternately, the inner wall of the stainless steel needle 48 may be provided with an electrodeposited, anodized silver layer, with conducting gel between this layer and the sensor body 46. A silver lead wire would then be WO 91/1~993 PCl/US91/02641 -13- 2080~22 conducLively secured ~o the inner needle surface. ln this embodiment, electri-cal current flows through the gel between the indicating electrode and the }eferencc f Icc~rod(.
Sensors constructed in accordance with Figs. 5-~, and using either external or implanted reference electrodes, give ~cct-nti~lly the same linear re-sponse as those constructed in accordance with Figs. 1-2.
Actual experience with sensors in acco,dance with the invention has desn-)nctrated that, upon implantation. the cells and capillaries of proximal ~issue are slightly damaged. After four or hve days, however, such tissues I0 lebene.dte around the sensor, forming a collagen layer. Neovascularization has also been observed in the collagen laver. and this phenomenon may partiall,v account for the sensitivity of the sensor. This is i~,di~~ , of o~e~aliol~ of the patien~'s immune system. In any event. the presence of a neovascularized collagen layer adjacent the impl~ntt-d sensor permits passage of oxygen and glucose. In addition, it has been found that in the first hours after implan-tation~ the sensor response is somewhat variable. Over time, however, this variability is de.,-~,ased and the p~.ro,--lance of the implanted sensor ir.~.eases.
This is believed to be due to the s~ r of the tissue around the implant-ed sensor. The end result is that the sensors of the present invention may be successfully implanted and left in place for periods of time heretofore thought a~ al~ e.g., periods of from seven days to three weeks are feasible.
Those skilled in the art will tln~lers~nfl that the sensors oF the inven-tion may require in vivo calibration. This would typically be done by measuring two blood glucose levels by conventional means, and correlating these known values wi~h the ou~pu~ of ~he sensor.
It will thus be seen that the enzymatic sensors in ac~o.dance with the invention exhibit ~.u~..,.~ics h~ ofo.t: difficult to achieve. inrlu-line small, fully implantable size; linearity in response over the concentration ranges of interest;
storage stability; and the abilily to be consistently manufactured without unduerejection rates.
- : .
.
.
.
Furthermore, many prior sensors do not exhibit a stable and linear response, particularly over PYt~nAed times of impl~nt~tinn, and do not give accurate and reliable results. Finally, fa~.icaLioll of prior glucose sensors has presented formidable difficulties, to the extent that only about one in five sensors pro-duced by ~,on~cnlional te.,l.n;~ues are deemed usable. This obviously repre-sents a considerable inefficiency, to the point that no truly successful implant-able glucose sensor has helel~role been p.uduced on a large scale.
Summar~ of the Invention The present invention o~e.~lllLs the plùbl_...s outlined above, and 1~ provides a greatly i--.~J~u.ed ~,.l~lllal;c sensor specifically designed for long-term impl~nt~tinn in a patient. The sensor is adapted Eor pncitinning in an em,hc l".,cnt characterized by the presence of biological mr~ ec which are substrates for or products y~os~uc~d by enzymes, in order to d~rmin~ the presence of such biological molecules. While the p.h~ci~lcs of the invention may be used in the fabrication of glucose sensors, the invention is not so limited. Indeed. the sensors in a~u,dancc with the invention may be produced using a wide variety of h..-..obil;~d enzymes. for the detection of an equally large number of analytes. Exemplary enzymes and their cullc~yonding sub-strates are given in U.S. Patent No. 4,721,677 to Clark, and this patent is incorporated by reference herein.
In any event, the enzymatic sensors in accordance with the invention preferably are in the form of an elongated body supporting at least an indicat-ing electrode, with the inrlir~ing electrode presenting a seclion adapted for exposure to the biological environment. The inr~ir~inv electrode section has an enzyme operably immobilized thereon to present an enzymatic inrlir~ing surface. A number of variants are possible for the reference electrode. For PY~m?la~ use may be made of an exteïlialiy applied eleciiocd~diog~ai" ~ic;"
electrode (an 8 mm disk covered with silver chloride and available as Model E-24~ frûm the Phymep Company, 21 Rue Campoformio, Paris, France)~ or a reference electrode which is implanted with the in(licating electrode.
WO 91/15993 PCl/US91/02641 3, 2080022 In one specific embodiment employing an implanted reference elec-trode, the indicating surface oE the irl-iir~ting electrode and the reference elec-trode are laterally spaced apart along the length of the body and each substan-tially ~h~,ulll~libes the latter and is sllhs~:lnti~lly exposed to the biological environment when the sensor is placed therein. Use oE such circumferentially f Ytentling enz~matic in~irating surfaces and reference electrodes sections is believed to be an important aspect of this embodiment. Alternately, the reference electrode section may c~ ..ise a CUIJdU~ Ve salt bridge ~ .Ulll~
ing the body and Iying in a plane transverse to the lon~itl.-iin~l axis of the body; in this case, a lcr~,~cnce electrode is placed in electrical contact with the salt bridge, through use oE a buffered electrolvte. In another embodiment, the reference electrode is simply placed adjacent the inrlirating electrode as a part of the overall sensor.
In preferred practice, the sensor body advantageously comprises an f 1~ lly COf~lu Li-,e noble metal ~e ~ pla~num or ~ iridium) electrode covered with electrically insulative material. with a portion of this material removed from the ele~ ,dc to define an enzyme--ccelvil~g zone. Thus, a short length of Teflon (polytetrafluoroethylene) coated platinum-iridium wire may be provided, with a short section of the inclll~tion removed intermediate the ends of the wire, so that respective segmt ntC of the incul~ting material are on opposite sides of and define a recessed enzyme-receiving .,i~culllfe~c.~lial zone.
Alternately, the endmost portion of the Teflon may be removed, leaving a protruding exposed stretch of wire which defines the enzyme-receiving zone.
An enzyme is operably immobilized on the exposed section of the platinum-iridium wire~ by known means such as adsorption of the enzyme on a cellulose acetate or Nafion layer (1-3 microns thirL-nf~cc), followed by cross linking with giutaraldehyde.
Another important aspect of the present in-ention resides in the preferred use of a synthetic polymer membrane disposed over the enzymatic in(iic~ting surEace to serve as a permeable protective layer. In particular. a layer of polyurethane is advantageously applied as a thin coating over at least thc inr~ ng su.facc (and ;;._.~ra'lj- thc clliirc inr1icat;np electroLlc) hi oruc~
to protect the el"yll~atic reaction surface from the biological environment.
Moreover, this layer provides a diffusional barrier Eor glucose which slows down3~ the flow of glucose and creates a linear sensor response over the concentration Wo 91/15993 PcltUS9l/o264 2 0 8 0 ~ 2 2 ranges of interest. In particular, in order to achieve the desired linear re-sponse, use is made of an active enzyme layer and a relatively thin protective membrane. It is important that the membrane regulate the passage of mole-cules therethrough to an extent that the enzymatic reaction between the in-iirating sur&ce and these molecules is determined by the rate of diffusion through the Illu~llblanC, and not the en_ymatic reaction kinetics. In practice using the methods of sensor construction herein described, an optimal balance between the ~ el;~& goals of linear response and se.~ ivily and response times may be achieved.
The use of an ad~ ;n~ negatively charged inner l"~,.. ,b,~.ne layer immlorliately adjacent the Pt-lr wire also retards the diffusion of negatively charged species (e.g. ascorbate and urate) in the biological e..vi.olll..-,..t which are interfering species. Of course, this inner ~ .,.b~dne does not cignifir~ntlyexclude hydrogen peroYide, an electrically neutral species.
Although the l1.~ ~ of the o~ l pol~e~l~an~ ' .......... ne has not been spe~ifir~lly ascertained, it is ~ctim~ted that the membrane has a of from about 5 to 10 microns in the p~f~ ;d glucose sensors hereof.
The sensors described above are, by virtue of their construction, relatively fleYible and therefore comfortable in use. However, this same cll&~ liaLic Ele,Yibility makes it nccessa,y to employ a catheter to implant thesensors. In an alternative embodi".~nt, sensors may be provided which can be readily implanted without the need of a catheter, even by the patient himself.
In such embodiments, use is made of an Plong~t~l tubular, metallic housing, typically a conventional hypodermic needle; the sensor apparatus is inserted within the needle, and includes an inrlirating electrode having a section thereof provided with immnbili7.od en_yme. In order to expose the en_yme to the biological environment, the needle sidewall is apertured in registry with the en_yme. A holder is also provided adjacent the rearward end of the needle body in order to facilitate manipulation and insertion of the sensor. This holder advantageously is in the form of a transversely PYtPn~ling flag-like plastic bv '; ..ccu,~d to the needle housing.
The invention also collll),ehel,da a novel method of applying the polyurethane membrane described previously. That is to say, a real difficulty inthe production of enzymatic sensors stems from the difficulty of applying .
WO 91/15993 PCl/US91/02641 2~8~022 various materials uniformly to a very small, implantable device. rnis difficultyhas been overcome in the context of the present invention, by applying to the sensor surface a well-defined volume of a polymer dissolved in an organic solvent such that lhe film is unitormly distributed across the surface. In S practice, this method is carried ou~ by providing a wire loop, and holding the coating liquid in the loop by sur&ce tension to form the desired polymer solu-tion droplet, followed by passing the electrodes through the loop to achieve uniform coating along the length of the sensor body.
The enzymatic sensors of the invention have an ideal geometry for imp!~ a~jon Generally spe~kingl the flexible units not housed within a needle are equivalenl in size and shape to a 26-gauge needle (i.e., about 0.45 mm.
oulside diameter). Moreover, ~heir geometry perrnits the reproducible deposi-tion of films and materials and allo vs careful control of the amount and orien~tinn of the enzyme onto the in~ a~ing electrode. hnally, the preferred ser~sors are e~f~Li~ "capped~ with ;~ n~~ (Te~n) which ~revents the sensors from penetrating further into the tissue than is required. Thus. the h~ ion of the sensor causes minimal trauma to the tissue and to the sensor itsel~ The sensor can flex laterally, and this again ...i~ tissue damage caused by movement of the patient.
In the case of implantable glucose sensors, response times of less than two minutes and linearities over glucose concc,nt~ations of 0-25 mM can be achieved. At the same time, through use of the fabrication ~C~ l~n;~lUf ~ of theinvention, the rejection rate upon initial m~nuf~t~lre is drastically reduced.
In the case of sensors received within a needle housing, such can be readily manipulated by the patient for implantation pUIl~OSCS. These sensors typically have a slightly larger diameter than the flexible sensors described previously, but are not so large as to cause ~ ;cco...folL. This relative-ly small size is assured because of the sensor construction, making use of a small Teflon-coated Pt-Ir wire and immobilized enzyme.
Brief De~iv ~c of the Druwin~s Figure I is an enlarged, sectional view illustrating a glucose sensor in accord~ncc; wiil~ e inv~nli~n;
Fig. 2 is an enlarged, sectif n~l view o~ another glucose sensor in accordance with the invention;
:' , .
, i, :, .. . . ~
WO 91/15993 PCI~/US91/02641 2 0 8 0 ~ 2 2 Fig. 3 is a graph showing the linear sensor response of the Fig. 1 glucose sensor over a glucose Col1CC~llrdtiOn range of 0-25 mM;
Fig. 4 is a graph illustrating the storage stability of the Fig. 1 glucose sensor;
Fig. 5 is a sectional view depicting another sensor embodiment wherein the inllicating electrode is housed within an impl~nt~hle needle:
Fig. 6 is a perspective view of the sensor illustrated in Fig. 5; and Fig. 7 is a p.,.S,~,~.,livc view of an emho~limpnt similar to that of Fig. 6.
but depicting the use of an implantable reference electrode.
D~ t- of the ~lef~ A ~,d F
The following ~.dlllples illustrate the construction of glucose sensors depicted in Figs. 1 and 2~ and are d~crrihed with particular ~c;Lelt,nce to the,se drawings. It will be understood. however, that the .oY~mplP5 are illustrative only, and nothing therein,should be taken as the limit~ti~n UpOli the overall scope of the i~.. ~
Example 1 - Fi~. 1 One end of a 10 cm section 10 of Medwire Co"~o~ation Teflon-Coated platinum-iridium wire is provided. The section 10 includes a central pl~tinllm_ iridium wire 12 (0.18 mm o.d.) and a coating of insulative Teflon 14 (0.035 mm shirlrnPc~) the.Garou"d. The central wire 12 forms the int~ir~ting electrode from the sensor. A cavity 16 (1-3 mm in length) is formed in the wire 10 as shown in Fig. 1. This is achieved by first putting a circular cut on the Teflon coating with a paper cutter and then pulling the Teflon out to create a cavity of about 1 millimf~ter in length, exposing a corr~pQn~ling section of the wire 12. The excess Teflon extending beyond the left end of the wire 12 is then trimmed off with the cutter.
The ~ ce electrode 18 is formed on the Teflon surface, about I.5 millim.oters to the right of thé exposed platinum iridium surface as viewed in Fig. 1. A thin silver wire (0.1 mm o.d., 15 cm length) is tightly wrapped aroundthe teflon surface covering to form a coil 20 of about 5 millimt~t.ors in length.
A wire wldpping tool may be utilized for this purpose. The trailing portion of the wirc ;u ih ;; liglli Or coil 20 i~ /VCICl wiin a section 22 of heal shriJI~cabi~
Teflon tubing (5 cm long, 1.5 mm o.d., Zeuss Industrial Products Inc.), leaving small lengths of the silver wire and platinum iridium wires uncovered to serve as electrical leads. A heat gun operating at 600~C is employed for shrinking , .
:. :
.
WO 9l/15993 PCltUS91/02641 -7- 2~0022 !j . '.j.
the Teflon tubing. A layer of silver chloride is formed on the coil 20 by passing current (0.4 mAlcm2) for 60 minutes through the wrapped silver wire while it is dipped in a stirred ().1 N HCL solution. The exposed por~ions of reterence electrode 18 are then rinsed with de-ionized water for 6 hours. The reference electrodes plepaled in this manner show a potential of -64 + 3 mV
(n=10) vs. Ag/AgCl(3M NaCl) in 0.15 M NaCl at 370C.
In order to immobilize glucose oxidase (GOx, E.C.1.1.3.4) on the exposed portion of wire 12, an inner, negatively charged l~ lblane is first applied to the exposed wire section. Thereaher. a circumferentially ~Y~.on~ling erlzymatic inrli~,q.~ing layer 21 is formed within cavity 16. Two different ap-plUd~,ll(.,S have been employed to achieve these ends.
Attqrhm~nt of GOx to bovine serum albumin coupled cellulose acetate The exposed platinum iridium surface within cavity 16 is degreased by washing with acetone. It is then rinsed with de-ionized water and dried in cold air stream before polymer deposition.
The left hand part of the sensor (portion to the left of the ~ ,nce electrode coil 20) is dipped into 5% cellulose acetate (39.8% acetyl content) inSO~o acetone and 50% ethanol for 10 seconds and is withdrawn slowly. It is 2~ then exposed to the vapor above the cellulose acetate solution for 5 seco.. ds and is dipped again into the cellulose acetate solution for 10 seconds. The sensor is then removed and dried in air at room temperature (230C) for one minute and placed in d.,;olliGed water for 6 hours to permit disp!qrPm~n~ by water of entrapped solvent in the llle.llbldne pores. The cellulose acetate Ill~lllI"dnc prepared in this fashion shows good long-term stability and also discriminates well against ascorbate and urate. Bovine serum albumin (BSA) is then covalently coupled to cellulose acetate and a subsequent reaction of the membrane with GOx~ which has previously been activated with an excess of p-benzoquinone, is carried oul. The detailed procedure for this reaction is described in the literature, Sternberg et. al.. Anal. Chem. 1988, 60~ 2781. which is incorporated herein by reference.
B. Physical adsorption of enzvme on cellulose acetate or Nafion followed by crocclinking with glutaraldehvde 1. The sensor is coated with cellulose acetate in exactly the same manner as described above to create membrane. The GOx (270 U/mg) is - . .
WO 91/15993 Pcr/US9l/o26 2 0 ~ O ~ 2 2 physically adsorbed by dropping 5 Ill of GOx solution (40 mg/Ml in 0.1M
phosphate buffered saline) on the in~lira~ing element within cavity 16, and is allowed to dry for 10 minu~es at room temperature. To immobilize the enzyme and form circumferential surface 21, the sensor is exposed to glutaraldehyde vapor generated from 25% glutaraldehyde solution placed at the bottom of an enclosed glass chamber for 12 hours at room temperature. The sensor is then rinsed in de-ioni~d water and dried in air for 2 hours. The croc~1inlcing with glutaraldehyde protects the enzyme from heat degradation, proteolytic enymes and hydrolysis, E.M. Salona. C. Saronio. and S. Garattini (eds), "Insolubilized Enz3nnes." Raven, New York, 1974, ;ncc"~uldted by rcfe.c.,~ herein.
2. Nafion (Perfluorosulfonic acid poly-mer. obtained from E.I. DuPont de Nemours and Co., m~ay~also be used as an ~Itlorn~e fûr cellulose acetale for the inner membrane. After cleaning the sensing portion of the sensor as above, it is electrocoated with Nafion using the method described by Adams e al, Neurosci. Meth VoL 2Z, I987, pp 167-172, illw~la~ by ,er~.~.. ~
herein. One drop of Nafion (5% solution, Aldrich) is placed in a 2 mm loop formed at one end of a copper wire. A DC potential of +3V is applied to the working electrode with respect to the loop for 10 seconds. The sensor is pulled out of the loop before turning off the potential and is dried in air for 2 hours, and the GOx enzyme is applied as described above.
Alternate polymers may be used in lieu of or in combination with cellulose acetate or Nafion for coating of the exposed Pt-Ir wire surface. For example, polyaniline and poly-phenol derivatives can be electroçhemir~lly deposited onto the exposed in~lira~ing electrode surface. Oxidative electro-polymerization of aniline and phenol monomer yields stable and adhesive coating over the exposed wire. These materials moreover have good size selec-tivity which can be utilized to further improve the sensor sele~,livily against electroch.ornir~l inte,~lences in biological envi.ollll.en~. The combination of a size selective coating with a charge selective film (e.g. cellulose acetate) mayreduce the in ~ivo background current and the risk of electroch~mic~l interfer-ence. Electropolymerization ot aniline and phenol is well known, see for exam?le Chsalca ei al. ~lal. Chelll. 19~7, J9, i7~ô-oi, ~nd ivia;;~ L~ e~ ai.
Anal. Chem. l990, 62, 2735-40, both of which are incorporated by reference herein.
.
:
9 20~0~22 Finally; Eastman-Kodak AQ 29-D polymer (poly (ester-sulfonic acid)) has both charge and size selective features, and may be applied ~o the exposed indicating electrode wire in lieu of Nafion. A coating of this type applied to the indicating electrode with a cellulose acetate layer thereover should improveoverall selectivity. Combined coatings made from miAtures of cellulose acetate and the AQ 29-D polymer should also provide advantages in terms of sensor selectivity.
In order to cc F'. e the plepala~ion of the sensor, the whole assembly, including the reference electrode~ is dip coated with 4% polyurethane (Thermedics, SG ~5A) dissolved in 98% tetrahydrofuran (l~ ) and 2%
dimethylformamide (DM~;) to form an outer membrane 24. The polyurethane solution (I0 uL) is held in a wire loop (2 mm i.d.) by surface tension and the sensor is passed through the loop. This leaves a uniform polymer film on the col p'cted sensor 25 to the api!.uy~ate extent depicted in Fig. I. This method l; provides a good control over Ihe arnount of po~rmer which is applied to the sensor. The sensor is dried in air for 6 hours at room temperature and then left in 0.I M i hosph~te buffered saline, pH=7.4 for 72 hours for the various outer membranes to co~ n fully. It is possible to recoat the sensor with polyurethane if the desired linear range of glucose sensitivity is not obtained after the first coating.
EAample 2 - Fii-~. 2 One end of a 10 cm section 26 of Teflon-coated platinum-iridium wire is provided having a 0.I8 mm o.d., a central Pt-Ir wire 28 and a teflon sheath 30 (0.035 mm thi~-lrnl-cs). The left hand end of the wire is stripped to form a ~ - .
cavity 32 as described in EAample I. The right hand end of section 26 is then inserted into a 5 c~ ntimf ~ers long polyethylene tube 34 (0.67 mm o.d., 0.30 mmi.d.). The left hand /_Alre.lli~y of the polyethylene tube is sealed by putting a drop of 4% cellulose acetate solution (in acetone)into the opening. The acetone is allowed to dry while holding the Tefion-coated wire in the middle of the polyethylene tube. This permits ~he formation of a circumferential salt bridge deposit 36 which effectively acts as the terminal part of the reference ciec~rodc, iics in ~ plane tran~ver~e ~ ~h~ ngitu~iin~i axis of the wire ~ anci establishes electrical contact between the reference and sensing electrodes.
The empty annular space between the Teflon-coated wire and the polyethylene tube is then filled under vacuum with 0.1 M phosph ~P buffer, pH = 7.4 con-.
' ' : : : ' ' : : :
- : :
- . . ., ~
Wo 91/15993 PCI/US9t/02641 2080~22 -10- ~
- taining 9 glL NaCI. A chloridized silver wire 38 (0.05 mm o.d. 5 cm long prepared as described in Example 1) is introduced inlo Ihe polyethylene tube Erom the righ~ hand end ~hereof and ~his opening is also sealed as described above ~o presen~ a sealing deposit 40. The reterence electrode shows a S potential of -60 + 10 mV (n=6) vs Ag/AgCI (saturated KCL) a~ 370C. The enzyme immobilization and polyurethane deposition steps are then carried out using the p~u._elulcs described in Example 1 to give the inner negatively charged Illclllblane 32a the u h- u~fe~ential in~ir~ing enyme layer 33 and outer permeable luclllb,dne 42 illustrated in Fig. ~. The complete sensor 43 is then ready for calibration and use with electrical ronn~l;o.~ afforded by the aYially ~Yten~ing ends oE the wires 28 38.
The sensors described in the above example are calibrated by dipping into a thermnsrAted cell (aL 370C) con~aining 10 ml of stirred 0.1 M phosphate buffered saline pH = 7.4 and a potential of +600 mV (for hydrogen peroxide leteetir~n) is applied between the work;ing and the . f .ence~ ; e elec-trodes. The background current is allowed to stabilize for 20 minutes. The calibration of the sensor is carried out by adding increasing amounts of glucose~o the stirred buffer. The current is measured at the plateau (steady state response) and is related to the concel ll~tion of the analyte. Following the calibration procedure the sensors are stored in 0.1 M phosphate buffered saline pH = 7.4 at room temperature.
A typical response curve to the glucose addition is shown in Figure 3 for a sensor made in accordance with Fig. 1. As illustrated. the response characteristics of the sensor over the concentration range of interest (0-25 mM) are essentially linear. and are especially so over the range oE 0-15 mM.
The sensor oulput is also essentially independent oE the stirring rate. The in vitro characteristics of the sensor are sullllll .li~ed in the following Table. A
typical storage stability cur~e for the sensor is shown in Figure 4. During the first few days of sensor preparation the polyurethane membrane changes its permeability for glucose as a result of hydrolytic and swelling processes. Ieading to the increased passage of glucose and an increased curren~. After this initialCliGu, L~/Wt;~c;r, ~h~ stability is f YrellPni The sensors of the invention are in use electrically coupled with suitable signal processing e~uipment. and implanted into a desired sl-hcl-~ne-ous site. Glucose and oY~ygen diffusing ~hrough ~he ou~er synthetic polymer .
..
' :
Wo 91/15993 PCl/US91J026~
2 ~ 2 2 l~ ~
membrane are enzymatically catalyzed by the GOX at the in~jca~ing surEace, resulting in production of gluconic acid and hydrogen peroxide. The latter is measured amperometrically, which is a measuremenl ol glucose concentration.
TABLE
In Vitro Characteristics of Fig. 1 Glucose Sensor Parameter Value Residual current (nA~mm~)a 0.7 + 0.2 Sensitivity (nA/mM mm2) 1.~ + O.g Linear Range (upper limit) (mM) 15 ~ 3 Response time (min.), T 90% 3.5 ~ 1 .. ..
Results shown above are expressed as mean + SD for six sensors.
a Residual currents are ll,ca~ul~:d after 1 hour of polarization.
Figs. 5 and 6 illustrate another sensor 44 in accordance with the invention. In this case, the sensor body 46 is received within a stainless steelhollow tubular needle 48.
The sensor body 46 includes an innermost~ Tetlon-coated, pla~inum-iridium wire 50 (90% Pt/10% Ir) having a total O.D. of about 0.2 mm and a cavity 52 formed therein as described in Example 1. The cavity 52 is approxi-mately 1.0 mm in length and is located about 3.0 mm from the tip of the wire 50. A glucose oxidase layer 54 is immobilized within the cavity 52. and com-prises a cellulose acetate polymer layer attached to the surface of the Pt-Ir wire, wilh g,ll~;o~c u)dd~ rl~cciin;cpd thl.Ju~ iuiaraid~hydt: unlu iht:: ceiluiose acetate. This procedure is in acco..lancc with Example 1.B.1. above. The en-tirety of the in~ira~ing electrode is then covered by a membrane 56 oE polyure-thane, again using the method set forth in Example 1.
. .: ~ . ' . :' ' .
... ,. . ~.: - . :-2 0 8 a o 2 2 The sensor body 46 is thereupon inserted into a 25-gauge disposable r - stainless steel hypodermic needle, the latter having an aperture 58 adjacent the l'orward~ sharpened insertion end 60 thereof. The sensor body 46 is installed insuch manner that the glucose oxidase layer 54 comes into registry with the sidewall opening 58, thereby exposing the layer 54 to the biological environ-ment. A silicone rubber plug 62 is installed in the forward end of the needle 48 as shown.
As illustrated in Fig. ~, the wire 50 extends rearwardly out of the end of needle 48, and is adapted to be connected with appropriate instrumenlation ~or I0 measuring glucose conce,.L~atiol1s. In order to seal the rearward end of the sensor 44. a bead 64 of epoxy is applied around the wire 50 and the butt end of the needle 48 and sensor body 46.
The overall sensor 44 is completed by provision of a holder 66 extend-ing transversely of the needle 48. The holder 66 is preferably in the form of a plastic sheet wrapped around the rearward end of the needle 4~ as shown. and secured by means of epoxy or polycyanoacrylate glue. The holder 66 permits ready manipulation and insertion of the sensor 44 even by the patient.
In the use of sensor 44, the reference electrode may be either external-ly applied or implanted. As an external electrode, use may be made of a commercial ele~lu~aldiogram skin electrode described previously may be used.
An external reference electrode should be applied in close plu~dl~ y to the impl~nted sensor for the best measurement results. The holder 66 may also be used to support an external electrode of the type described previously. Inas-much as the holder lies closely adjacent the skin upon implantation, the holder may serve as an ideal platform for the external electrode.
Fig, 7 illustrates an embodiment wherein use is made of an implantable reference electrode. In this case, the needle 48 has an electrodepoci~Pd layer 68 of silver on the external surface thereof, with this layer being ;lnotli7Pd in the presence of chloride ion to create a Ag/AgCI reference electrode. A silver lead wire 70 is conductively affLxed to the rearward end of needle 48 by means of silver epoxy or similar expedient, and the holder 66 is wrapped about this conneciior. aS ;.how.l.
Alternately, the inner wall of the stainless steel needle 48 may be provided with an electrodeposited, anodized silver layer, with conducting gel between this layer and the sensor body 46. A silver lead wire would then be WO 91/1~993 PCl/US91/02641 -13- 2080~22 conducLively secured ~o the inner needle surface. ln this embodiment, electri-cal current flows through the gel between the indicating electrode and the }eferencc f Icc~rod(.
Sensors constructed in accordance with Figs. 5-~, and using either external or implanted reference electrodes, give ~cct-nti~lly the same linear re-sponse as those constructed in accordance with Figs. 1-2.
Actual experience with sensors in acco,dance with the invention has desn-)nctrated that, upon implantation. the cells and capillaries of proximal ~issue are slightly damaged. After four or hve days, however, such tissues I0 lebene.dte around the sensor, forming a collagen layer. Neovascularization has also been observed in the collagen laver. and this phenomenon may partiall,v account for the sensitivity of the sensor. This is i~,di~~ , of o~e~aliol~ of the patien~'s immune system. In any event. the presence of a neovascularized collagen layer adjacent the impl~ntt-d sensor permits passage of oxygen and glucose. In addition, it has been found that in the first hours after implan-tation~ the sensor response is somewhat variable. Over time, however, this variability is de.,-~,ased and the p~.ro,--lance of the implanted sensor ir.~.eases.
This is believed to be due to the s~ r of the tissue around the implant-ed sensor. The end result is that the sensors of the present invention may be successfully implanted and left in place for periods of time heretofore thought a~ al~ e.g., periods of from seven days to three weeks are feasible.
Those skilled in the art will tln~lers~nfl that the sensors oF the inven-tion may require in vivo calibration. This would typically be done by measuring two blood glucose levels by conventional means, and correlating these known values wi~h the ou~pu~ of ~he sensor.
It will thus be seen that the enzymatic sensors in ac~o.dance with the invention exhibit ~.u~..,.~ics h~ ofo.t: difficult to achieve. inrlu-line small, fully implantable size; linearity in response over the concentration ranges of interest;
storage stability; and the abilily to be consistently manufactured without unduerejection rates.
- : .
.
.
.
Claims (13)
1. A sensor adapted for positioning in an environment characterized by the presence of biological molecules which are substrates for or products produced by enzymes in order to determine the presence of said molecules, said sensor comprising:
an elongated flexible body comprising a length of electrically conductive indicating electrode wire covered with an electrically insulative material, there being a portion of said material removed from said electrode wire to define an enzyme-receiving zone;
an enzyme operably immobilized on said zone to present an enzymatic indicating surface;
a reference electrode supported on said body and presenting a section adapted for exposure to said environment, said indicating surface and said reference electrode section being laterally spaced apart along the length of said body and each substantially circumscribing the body, substantially the entireties of said circumscribing indicating surface and said circumscribing reference electrode section being exposed for reaction with said environment when the sensor is placed therein, said indicating electrode wire serving to support said sensor within said environment without the need for a carrier.
an elongated flexible body comprising a length of electrically conductive indicating electrode wire covered with an electrically insulative material, there being a portion of said material removed from said electrode wire to define an enzyme-receiving zone;
an enzyme operably immobilized on said zone to present an enzymatic indicating surface;
a reference electrode supported on said body and presenting a section adapted for exposure to said environment, said indicating surface and said reference electrode section being laterally spaced apart along the length of said body and each substantially circumscribing the body, substantially the entireties of said circumscribing indicating surface and said circumscribing reference electrode section being exposed for reaction with said environment when the sensor is placed therein, said indicating electrode wire serving to support said sensor within said environment without the need for a carrier.
2. The sensor of claim 1, said indicating surface being located intermediate the ends of said length of electrode wire with respective segments of said insulating material being on opposite sides of and defining said enzyme receiving zone.
3. The sensor of claim 1, said reference electrode comprising a coil disposed about said body.
4. The sensor of claim 1, said reference section comprising a conductive reference terminal lying in a plane transverse to the longitudinal axis of said body.
5. The sensor of claim 1, including an outer synthetic polymer membrane disposed over said indicating surface and reference electrode section, said membrane being permeable to said biological molecules.
6. The sensor of claim 5, said membrane being formed of polyurethane.
7. The sensor of claim 5, said membrane having a thickness of from about 5 to 10 microns.
8. The sensor of claim 1, including an inner membrane applied to said electrode wire along the length of said enzyme-receiving zone.
9. The sensor of claim 8, said membrane being negatively charged.
10. The sensor of claim 1, said sensor being a glucose sensor.
11. In a method of fabricating an enzymatic sensor including the steps of providing an indicating electrode and operably immobilizing an enzyme on said indicating electrode, the improvement which comprises the step of uniformly coating said electrodes with a synthetic polymer membrane, said coating step including the step of establishing a droplet of polymer solution ofdefined volume, and passing said electrodes through said film to coat the same.
12. The method of claim 11, said film establishing and passing steps comprising providing a wire loop, holding the liquid in said loop by surface tension, to form said film, and passing the electrode through the loop.
13. In an electrochemical sensor adapted to be inserted through the skin of a user and having an elongated, tubular housing presenting a sharpened insertion end and an opposed end with electrochemical sensor means for detecting an in vivo chemical condition carried within the housing and conductor means operably coupled with the sensor means and extending out of said opposed housing end, the improvement which comprises a holder for facilitating manipulation of the housing and insertion thereof through a user's skin, said holder including a transversely extending body secured to said housing adjacent said opposed end and permitting manual grasping and manipulation of the housing, said housing presenting a conductor-clearing opening generally aligned with the longitudinal axis of said tubular housing forpermitting said conductor means to extend out of said tubular housing and past said body.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51104990A | 1990-04-19 | 1990-04-19 | |
US511,049 | 1990-04-19 | ||
US07/682,560 US5165407A (en) | 1990-04-19 | 1991-04-09 | Implantable glucose sensor |
US682,560 | 1991-04-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2080022A1 CA2080022A1 (en) | 1991-10-20 |
CA2080022C true CA2080022C (en) | 1997-12-23 |
Family
ID=27057105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002080022A Expired - Fee Related CA2080022C (en) | 1990-04-19 | 1991-04-17 | Implantable glucose sensor |
Country Status (11)
Country | Link |
---|---|
US (1) | US5165407A (en) |
EP (1) | EP0525127B1 (en) |
JP (1) | JP3194434B2 (en) |
AT (1) | ATE194062T1 (en) |
AU (1) | AU640785B2 (en) |
CA (1) | CA2080022C (en) |
DE (1) | DE69132270T2 (en) |
DK (1) | DK0525127T3 (en) |
ES (1) | ES2148154T3 (en) |
GR (1) | GR3034376T3 (en) |
WO (1) | WO1991015993A1 (en) |
Families Citing this family (573)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5431160A (en) * | 1989-07-19 | 1995-07-11 | University Of New Mexico | Miniature implantable refillable glucose sensor and material therefor |
TW279133B (en) * | 1990-12-13 | 1996-06-21 | Elan Med Tech | |
US5593852A (en) | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
JPH04278450A (en) | 1991-03-04 | 1992-10-05 | Adam Heller | Biosensor and method for analyzing subject |
US5284140A (en) * | 1992-02-11 | 1994-02-08 | Eli Lilly And Company | Acrylic copolymer membranes for biosensors |
US5956501A (en) * | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
US5299571A (en) * | 1993-01-22 | 1994-04-05 | Eli Lilly And Company | Apparatus and method for implantation of sensors |
GB9304306D0 (en) * | 1993-03-03 | 1993-04-21 | Univ Alberta | Glucose sensor |
US5497772A (en) * | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
DE4401400A1 (en) * | 1994-01-19 | 1995-07-20 | Ernst Prof Dr Pfeiffer | Method and arrangement for continuously monitoring the concentration of a metabolite |
US5651767A (en) * | 1994-05-06 | 1997-07-29 | Alfred F. Mann Foundation For Scientific Research | Replaceable catheter system for physiological sensors, stimulating electrodes and/or implantable fluid delivery systems |
US5484404A (en) * | 1994-05-06 | 1996-01-16 | Alfred E. Mann Foundation For Scientific Research | Replaceable catheter system for physiological sensors, tissue stimulating electrodes and/or implantable fluid delivery systems |
US5513636A (en) * | 1994-08-12 | 1996-05-07 | Cb-Carmel Biotechnology Ltd. | Implantable sensor chip |
US5624537A (en) * | 1994-09-20 | 1997-04-29 | The University Of British Columbia - University-Industry Liaison Office | Biosensor and interface membrane |
IE72524B1 (en) * | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
US5586553A (en) * | 1995-02-16 | 1996-12-24 | Minimed Inc. | Transcutaneous sensor insertion set |
US5786439A (en) | 1996-10-24 | 1998-07-28 | Minimed Inc. | Hydrophilic, swellable coatings for biosensors |
US5882494A (en) * | 1995-03-27 | 1999-03-16 | Minimed, Inc. | Polyurethane/polyurea compositions containing silicone for biosensor membranes |
US5665065A (en) * | 1995-05-26 | 1997-09-09 | Minimed Inc. | Medication infusion device with blood glucose data input |
US5972199A (en) * | 1995-10-11 | 1999-10-26 | E. Heller & Company | Electrochemical analyte sensors using thermostable peroxidase |
US6689265B2 (en) | 1995-10-11 | 2004-02-10 | Therasense, Inc. | Electrochemical analyte sensors using thermostable soybean peroxidase |
US5711861A (en) | 1995-11-22 | 1998-01-27 | Ward; W. Kenneth | Device for monitoring changes in analyte concentration |
CA2212826C (en) | 1995-12-28 | 2002-02-19 | Cygnus, Inc. | Methods for monitoring a physiological analyte |
US5954685A (en) * | 1996-05-24 | 1999-09-21 | Cygnus, Inc. | Electrochemical sensor with dual purpose electrode |
JP3394262B2 (en) | 1997-02-06 | 2003-04-07 | セラセンス、インク. | Small volume in vitro analyte sensor |
US6741877B1 (en) * | 1997-03-04 | 2004-05-25 | Dexcom, Inc. | Device and method for determining analyte levels |
US6862465B2 (en) | 1997-03-04 | 2005-03-01 | Dexcom, Inc. | Device and method for determining analyte levels |
US8527026B2 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
US7899511B2 (en) * | 2004-07-13 | 2011-03-01 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
US7192450B2 (en) | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US9155496B2 (en) | 1997-03-04 | 2015-10-13 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
US5954643A (en) * | 1997-06-09 | 1999-09-21 | Minimid Inc. | Insertion set for a transcutaneous sensor |
AU8031898A (en) | 1997-06-16 | 1999-01-04 | Elan Medical Technologies Limited | Methods of calibrating and testing a sensor for (in vivo) measurement of an analyte and devices for use in such methods |
US5919216A (en) * | 1997-06-16 | 1999-07-06 | Medtronic, Inc. | System and method for enhancement of glucose production by stimulation of pancreatic beta cells |
US6093167A (en) * | 1997-06-16 | 2000-07-25 | Medtronic, Inc. | System for pancreatic stimulation and glucose measurement |
US6764581B1 (en) * | 1997-09-05 | 2004-07-20 | Abbott Laboratories | Electrode with thin working layer |
US6259937B1 (en) * | 1997-09-12 | 2001-07-10 | Alfred E. Mann Foundation | Implantable substrate sensor |
US6088608A (en) | 1997-10-20 | 2000-07-11 | Alfred E. Mann Foundation | Electrochemical sensor and integrity tests therefor |
US6081736A (en) | 1997-10-20 | 2000-06-27 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems adapted for long term use |
US6119028A (en) | 1997-10-20 | 2000-09-12 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces |
US6579690B1 (en) * | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
US7066884B2 (en) * | 1998-01-08 | 2006-06-27 | Sontra Medical, Inc. | System, method, and device for non-invasive body fluid sampling and analysis |
US8287483B2 (en) * | 1998-01-08 | 2012-10-16 | Echo Therapeutics, Inc. | Method and apparatus for enhancement of transdermal transport |
US6103033A (en) | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6251260B1 (en) | 1998-08-24 | 2001-06-26 | Therasense, Inc. | Potentiometric sensors for analytic determination |
CA2666434A1 (en) * | 1998-10-08 | 2000-04-13 | Medtronic Minimed, Inc. | Telemetered characteristic monitor system |
US6591125B1 (en) | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US7621893B2 (en) | 1998-10-29 | 2009-11-24 | Medtronic Minimed, Inc. | Methods and apparatuses for detecting occlusions in an ambulatory infusion pump |
US7766873B2 (en) | 1998-10-29 | 2010-08-03 | Medtronic Minimed, Inc. | Method and apparatus for detecting occlusions in an ambulatory infusion pump |
US20040171980A1 (en) * | 1998-12-18 | 2004-09-02 | Sontra Medical, Inc. | Method and apparatus for enhancement of transdermal transport |
US7806886B2 (en) | 1999-06-03 | 2010-10-05 | Medtronic Minimed, Inc. | Apparatus and method for controlling insulin infusion with state variable feedback |
WO2000078992A2 (en) | 1999-06-18 | 2000-12-28 | Therasense, Inc. | Mass transport limited in vivo analyte sensor |
AT408182B (en) | 1999-09-17 | 2001-09-25 | Schaupp Lukas Dipl Ing Dr Tech | DEVICE FOR VIVO MEASURING SIZES IN LIVING ORGANISMS |
DE60028991T2 (en) * | 1999-10-07 | 2007-02-08 | Pepex Biomedical, LLC, Alameda | A sensor comprising an insulating sheath containing therein a plurality of conductive fibers at least partially surrounded by a sensitive material and containing voids between the fibers |
US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
JP3985022B2 (en) * | 1999-11-08 | 2007-10-03 | アークレイ株式会社 | Body fluid measuring device and insertion body used by being inserted into the body fluid measuring device |
US7003336B2 (en) | 2000-02-10 | 2006-02-21 | Medtronic Minimed, Inc. | Analyte sensor method of making the same |
CA2395868C (en) * | 2000-02-10 | 2009-07-14 | Medtronic Minimed, Inc. | Improved analyte sensor and method of making the same |
US6484045B1 (en) | 2000-02-10 | 2002-11-19 | Medtronic Minimed, Inc. | Analyte sensor and method of making the same |
US20030060765A1 (en) * | 2000-02-16 | 2003-03-27 | Arthur Campbell | Infusion device menu structure and method of using the same |
CA2406814A1 (en) | 2000-03-17 | 2001-09-20 | F. Hoffmann-La Roche Ag | Implantable analyte sensor |
US6405066B1 (en) | 2000-03-17 | 2002-06-11 | The Regents Of The University Of California | Implantable analyte sensor |
CN1277589C (en) * | 2000-05-31 | 2006-10-04 | 超治疗股份有限公司 | Electropancreatography |
US6540890B1 (en) * | 2000-11-01 | 2003-04-01 | Roche Diagnostics Corporation | Biosensor |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US6613379B2 (en) | 2001-05-08 | 2003-09-02 | Isense Corp. | Implantable analyte sensor |
US6932894B2 (en) | 2001-05-15 | 2005-08-23 | Therasense, Inc. | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
JP4681795B2 (en) | 2001-05-18 | 2011-05-11 | デカ・プロダクツ・リミテッド・パートナーシップ | Fluid pump infusion set |
US8034026B2 (en) | 2001-05-18 | 2011-10-11 | Deka Products Limited Partnership | Infusion pump assembly |
US6793632B2 (en) * | 2001-06-12 | 2004-09-21 | Lifescan, Inc. | Percutaneous biological fluid constituent sampling and measurement devices and methods |
US6702857B2 (en) | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
US20030032874A1 (en) | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
US6827702B2 (en) | 2001-09-07 | 2004-12-07 | Medtronic Minimed, Inc. | Safety limits for closed-loop infusion pump control |
US6915147B2 (en) * | 2001-09-07 | 2005-07-05 | Medtronic Minimed, Inc. | Sensing apparatus and process |
US6814845B2 (en) | 2001-11-21 | 2004-11-09 | University Of Kansas | Method for depositing an enzyme on an electrically conductive substrate |
US6952604B2 (en) | 2001-12-21 | 2005-10-04 | Becton, Dickinson And Company | Minimally-invasive system and method for monitoring analyte levels |
US20030153026A1 (en) * | 2002-01-04 | 2003-08-14 | Javier Alarcon | Entrapped binding protein as biosensors |
US6855556B2 (en) | 2002-01-04 | 2005-02-15 | Becton, Dickinson And Company | Binding protein as biosensors |
US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US7379765B2 (en) | 2003-07-25 | 2008-05-27 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
US8858434B2 (en) | 2004-07-13 | 2014-10-14 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US9282925B2 (en) | 2002-02-12 | 2016-03-15 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US20070227907A1 (en) * | 2006-04-04 | 2007-10-04 | Rajiv Shah | Methods and materials for controlling the electrochemistry of analyte sensors |
US7813780B2 (en) | 2005-12-13 | 2010-10-12 | Medtronic Minimed, Inc. | Biosensors and methods for making and using them |
US9492111B2 (en) * | 2002-04-22 | 2016-11-15 | Medtronic Minimed, Inc. | Methods and materials for stabilizing analyte sensors |
US7226978B2 (en) | 2002-05-22 | 2007-06-05 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US8996090B2 (en) * | 2002-06-03 | 2015-03-31 | Exostat Medical, Inc. | Noninvasive detection of a physiologic parameter within a body tissue of a patient |
US7261733B1 (en) * | 2002-06-07 | 2007-08-28 | Endovascular Technologies, Inc. | Endovascular graft with sensors design and attachment methods |
US7278983B2 (en) * | 2002-07-24 | 2007-10-09 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
US8512276B2 (en) * | 2002-07-24 | 2013-08-20 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US20040068230A1 (en) * | 2002-07-24 | 2004-04-08 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US7162289B2 (en) * | 2002-09-27 | 2007-01-09 | Medtronic Minimed, Inc. | Method and apparatus for enhancing the integrity of an implantable sensor device |
US8003513B2 (en) * | 2002-09-27 | 2011-08-23 | Medtronic Minimed, Inc. | Multilayer circuit devices and manufacturing methods using electroplated sacrificial structures |
US20040061232A1 (en) * | 2002-09-27 | 2004-04-01 | Medtronic Minimed, Inc. | Multilayer substrate |
US6770729B2 (en) * | 2002-09-30 | 2004-08-03 | Medtronic Minimed, Inc. | Polymer compositions containing bioactive agents and methods for their use |
US20050272989A1 (en) * | 2004-06-04 | 2005-12-08 | Medtronic Minimed, Inc. | Analyte sensors and methods for making and using them |
US9237865B2 (en) * | 2002-10-18 | 2016-01-19 | Medtronic Minimed, Inc. | Analyte sensors and methods for making and using them |
US20040074785A1 (en) * | 2002-10-18 | 2004-04-22 | Holker James D. | Analyte sensors and methods for making them |
US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US20040122353A1 (en) | 2002-12-19 | 2004-06-24 | Medtronic Minimed, Inc. | Relay device for transferring information between a sensor system and a fluid delivery system |
US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US6965791B1 (en) * | 2003-03-26 | 2005-11-15 | Sorenson Medical, Inc. | Implantable biosensor system, apparatus and method |
US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US7875293B2 (en) | 2003-05-21 | 2011-01-25 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
US7862519B1 (en) | 2003-05-21 | 2011-01-04 | Isense Corporation | Easy-to-use multi-use body fluid specimen collection and analyte sensing assembly |
US7225008B1 (en) | 2003-05-21 | 2007-05-29 | Isense Corporation | Multiple use analyte sensing assembly |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US7146202B2 (en) * | 2003-06-16 | 2006-12-05 | Isense Corporation | Compound material analyte sensor |
US9763609B2 (en) | 2003-07-25 | 2017-09-19 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
WO2007120442A2 (en) | 2003-07-25 | 2007-10-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8423113B2 (en) | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US20050176136A1 (en) * | 2003-11-19 | 2005-08-11 | Dexcom, Inc. | Afinity domain for analyte sensor |
JP2007500336A (en) | 2003-07-25 | 2007-01-11 | デックスコム・インコーポレーテッド | Electrode system for electrochemical sensors |
US8845536B2 (en) | 2003-08-01 | 2014-09-30 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8886273B2 (en) | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7519408B2 (en) | 2003-11-19 | 2009-04-14 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US6931327B2 (en) | 2003-08-01 | 2005-08-16 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US7959569B2 (en) | 2003-08-01 | 2011-06-14 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8160669B2 (en) | 2003-08-01 | 2012-04-17 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8761856B2 (en) | 2003-08-01 | 2014-06-24 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8626257B2 (en) | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | Analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US20100168657A1 (en) | 2003-08-01 | 2010-07-01 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US8369919B2 (en) | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7529574B2 (en) * | 2003-08-14 | 2009-05-05 | Isense Corporation | Method of constructing a biosensor |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US20140121989A1 (en) | 2003-08-22 | 2014-05-01 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
CN100479750C (en) * | 2003-09-02 | 2009-04-22 | 早出广司 | Glucose sensor and glucose level measuring apparatus |
US7630747B2 (en) * | 2003-09-09 | 2009-12-08 | Keimar, Inc. | Apparatus for ascertaining blood characteristics and probe for use therewith |
US7433727B2 (en) * | 2003-09-24 | 2008-10-07 | Legacy Good Samaritan Hospital And Medical Center | Implantable biosensor |
GB0324450D0 (en) * | 2003-10-20 | 2003-11-19 | Alertis Medical As | Sensor |
US7299082B2 (en) | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
USD914881S1 (en) | 2003-11-05 | 2021-03-30 | Abbott Diabetes Care Inc. | Analyte sensor electronic mount |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8532730B2 (en) | 2006-10-04 | 2013-09-10 | Dexcom, Inc. | Analyte sensor |
US8425417B2 (en) | 2003-12-05 | 2013-04-23 | Dexcom, Inc. | Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
EP1711790B1 (en) | 2003-12-05 | 2010-09-08 | DexCom, Inc. | Calibration techniques for a continuous analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8364230B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US8425416B2 (en) | 2006-10-04 | 2013-04-23 | Dexcom, Inc. | Analyte sensor |
US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
WO2005057173A2 (en) | 2003-12-08 | 2005-06-23 | Dexcom, Inc. | Systems and methods for improving electrochemical analyte sensors |
EP1711791B1 (en) | 2003-12-09 | 2014-10-15 | DexCom, Inc. | Signal processing for continuous analyte sensor |
US7637868B2 (en) | 2004-01-12 | 2009-12-29 | Dexcom, Inc. | Composite material for implantable device |
WO2005089103A2 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US8792955B2 (en) | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
WO2005119524A2 (en) | 2004-06-04 | 2005-12-15 | Therasense, Inc. | Diabetes care host-client architecture and data management system |
JP4799557B2 (en) * | 2004-06-09 | 2011-10-26 | ベクトン・ディキンソン・アンド・カンパニー | Multi-sample sensor |
US20070100222A1 (en) * | 2004-06-14 | 2007-05-03 | Metronic Minimed, Inc. | Analyte sensing apparatus for hospital use |
EP2335566A1 (en) * | 2004-06-16 | 2011-06-22 | iSense Corporation | Compound metal analyte sensor |
US7783333B2 (en) * | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
US7905833B2 (en) | 2004-07-13 | 2011-03-15 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8452368B2 (en) | 2004-07-13 | 2013-05-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8565848B2 (en) | 2004-07-13 | 2013-10-22 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7857760B2 (en) | 2004-07-13 | 2010-12-28 | Dexcom, Inc. | Analyte sensor |
US20060270922A1 (en) * | 2004-07-13 | 2006-11-30 | Brauker James H | Analyte sensor |
EP2335581A1 (en) * | 2004-07-13 | 2011-06-22 | DexCom, Inc. | Transcutaneous analyte sensor |
US7344500B2 (en) | 2004-07-27 | 2008-03-18 | Medtronic Minimed, Inc. | Sensing system with auxiliary display |
WO2006127023A2 (en) * | 2004-08-24 | 2006-11-30 | University Of South Florida | Epoxy enhanced polymer membrane to increase durability of biosensors |
US20060094944A1 (en) | 2004-10-28 | 2006-05-04 | Sontra Medical Corporation | System and method for analyte sampling and analysis with error correction |
US7303543B1 (en) | 2004-12-03 | 2007-12-04 | Medtronic Minimed, Inc. | Medication infusion set |
US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
US20090105569A1 (en) | 2006-04-28 | 2009-04-23 | Abbott Diabetes Care, Inc. | Introducer Assembly and Methods of Use |
US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
US7731657B2 (en) | 2005-08-30 | 2010-06-08 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
US9351669B2 (en) | 2009-09-30 | 2016-05-31 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US9572534B2 (en) | 2010-06-29 | 2017-02-21 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US7883464B2 (en) | 2005-09-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US8571624B2 (en) | 2004-12-29 | 2013-10-29 | Abbott Diabetes Care Inc. | Method and apparatus for mounting a data transmission device in a communication system |
US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
US7704229B2 (en) | 2005-02-03 | 2010-04-27 | Medtronic Minimed, Inc. | Insertion device |
US20090076360A1 (en) | 2007-09-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
WO2006110193A2 (en) * | 2005-04-08 | 2006-10-19 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
US8060174B2 (en) | 2005-04-15 | 2011-11-15 | Dexcom, Inc. | Analyte sensing biointerface |
EP1874179A2 (en) * | 2005-04-25 | 2008-01-09 | Infotonics Technology Center, Inc. | Microneedle with glucose sensor and method thereof |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US20060272652A1 (en) * | 2005-06-03 | 2006-12-07 | Medtronic Minimed, Inc. | Virtual patient software system for educating and treating individuals with diabetes |
US20070016449A1 (en) * | 2005-06-29 | 2007-01-18 | Gary Cohen | Flexible glucose analysis using varying time report deltas and configurable glucose target ranges |
US20090227855A1 (en) | 2005-08-16 | 2009-09-10 | Medtronic Minimed, Inc. | Controller device for an infusion pump |
US7737581B2 (en) | 2005-08-16 | 2010-06-15 | Medtronic Minimed, Inc. | Method and apparatus for predicting end of battery life |
US20080314395A1 (en) | 2005-08-31 | 2008-12-25 | Theuniversity Of Virginia Patent Foundation | Accuracy of Continuous Glucose Sensors |
US7713240B2 (en) | 2005-09-13 | 2010-05-11 | Medtronic Minimed, Inc. | Modular external infusion device |
US9072476B2 (en) | 2005-09-23 | 2015-07-07 | Medtronic Minimed, Inc. | Flexible sensor apparatus |
US7725148B2 (en) | 2005-09-23 | 2010-05-25 | Medtronic Minimed, Inc. | Sensor with layered electrodes |
US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
US8880138B2 (en) | 2005-09-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Device for channeling fluid and methods of use |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US7432069B2 (en) | 2005-12-05 | 2008-10-07 | Sontra Medical Corporation | Biocompatible chemically crosslinked hydrogels for glucose sensing |
CA2636034A1 (en) | 2005-12-28 | 2007-10-25 | Abbott Diabetes Care Inc. | Medical device insertion |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US8114268B2 (en) | 2005-12-30 | 2012-02-14 | Medtronic Minimed, Inc. | Method and system for remedying sensor malfunctions detected by electrochemical impedance spectroscopy |
US8114269B2 (en) | 2005-12-30 | 2012-02-14 | Medtronic Minimed, Inc. | System and method for determining the point of hydration and proper time to apply potential to a glucose sensor |
US7774038B2 (en) | 2005-12-30 | 2010-08-10 | Medtronic Minimed, Inc. | Real-time self-calibrating sensor system and method |
US20070173712A1 (en) * | 2005-12-30 | 2007-07-26 | Medtronic Minimed, Inc. | Method of and system for stabilization of sensors |
US20070169533A1 (en) | 2005-12-30 | 2007-07-26 | Medtronic Minimed, Inc. | Methods and systems for detecting the hydration of sensors |
US7985330B2 (en) | 2005-12-30 | 2011-07-26 | Medtronic Minimed, Inc. | Method and system for detecting age, hydration, and functional states of sensors using electrochemical impedance spectroscopy |
US9757061B2 (en) | 2006-01-17 | 2017-09-12 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US7736310B2 (en) | 2006-01-30 | 2010-06-15 | Abbott Diabetes Care Inc. | On-body medical device securement |
WO2007095093A2 (en) | 2006-02-09 | 2007-08-23 | Deka Products Limited Partnership | Pumping fluid delivery systems and methods using force application assembly |
US11478623B2 (en) | 2006-02-09 | 2022-10-25 | Deka Products Limited Partnership | Infusion pump assembly |
US11364335B2 (en) | 2006-02-09 | 2022-06-21 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US11027058B2 (en) | 2006-02-09 | 2021-06-08 | Deka Products Limited Partnership | Infusion pump assembly |
US11497846B2 (en) | 2006-02-09 | 2022-11-15 | Deka Products Limited Partnership | Patch-sized fluid delivery systems and methods |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
US7826879B2 (en) | 2006-02-28 | 2010-11-02 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
EP1991110B1 (en) | 2006-03-09 | 2018-11-07 | DexCom, Inc. | Systems and methods for processing analyte sensor data |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US7801582B2 (en) | 2006-03-31 | 2010-09-21 | Abbott Diabetes Care Inc. | Analyte monitoring and management system and methods therefor |
US8374668B1 (en) | 2007-10-23 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte sensor with lag compensation |
US8224415B2 (en) | 2009-01-29 | 2012-07-17 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
US7653425B2 (en) | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8473022B2 (en) | 2008-01-31 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte sensor with time lag compensation |
US9675290B2 (en) | 2012-10-30 | 2017-06-13 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US7630748B2 (en) | 2006-10-25 | 2009-12-08 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US9392969B2 (en) | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
WO2007120381A2 (en) | 2006-04-14 | 2007-10-25 | Dexcom, Inc. | Analyte sensor |
US7942844B2 (en) | 2006-04-28 | 2011-05-17 | Medtronic Minimed, Inc. | Remote monitoring for networked fluid infusion systems |
US8073008B2 (en) | 2006-04-28 | 2011-12-06 | Medtronic Minimed, Inc. | Subnetwork synchronization and variable transmit synchronization techniques for a wireless medical device network |
US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
WO2008105791A2 (en) | 2006-06-22 | 2008-09-04 | University Of South Florida | Collagen scaffolds, medical implants with same and methods of use |
US20110054391A1 (en) * | 2006-07-28 | 2011-03-03 | Ward W Kenneth | Analyte sensing and response system |
US7831287B2 (en) | 2006-10-04 | 2010-11-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8447376B2 (en) | 2006-10-04 | 2013-05-21 | Dexcom, Inc. | Analyte sensor |
US8449464B2 (en) | 2006-10-04 | 2013-05-28 | Dexcom, Inc. | Analyte sensor |
US8562528B2 (en) | 2006-10-04 | 2013-10-22 | Dexcom, Inc. | Analyte sensor |
US8298142B2 (en) | 2006-10-04 | 2012-10-30 | Dexcom, Inc. | Analyte sensor |
US8478377B2 (en) | 2006-10-04 | 2013-07-02 | Dexcom, Inc. | Analyte sensor |
US8275438B2 (en) | 2006-10-04 | 2012-09-25 | Dexcom, Inc. | Analyte sensor |
US8135548B2 (en) | 2006-10-26 | 2012-03-13 | Abbott Diabetes Care Inc. | Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors |
US10154804B2 (en) | 2007-01-31 | 2018-12-18 | Medtronic Minimed, Inc. | Model predictive method and system for controlling and supervising insulin infusion |
US20080199894A1 (en) | 2007-02-15 | 2008-08-21 | Abbott Diabetes Care, Inc. | Device and method for automatic data acquisition and/or detection |
US8121857B2 (en) | 2007-02-15 | 2012-02-21 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US8812071B2 (en) | 2007-03-07 | 2014-08-19 | Echo Therapeutics, Inc. | Transdermal analyte monitoring systems and methods for analyte detection |
US20100113897A1 (en) * | 2007-03-19 | 2010-05-06 | Bayer Health Care Llc | Continuous analyte monitoring assembly and methods of using the same |
US20080249383A1 (en) * | 2007-04-04 | 2008-10-09 | Isense Corporation | Analyte sensing device having one or more sensing electrodes |
CA2683721C (en) | 2007-04-14 | 2017-05-23 | Abbott Diabetes Care Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
EP2146624B1 (en) | 2007-04-14 | 2020-03-25 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
EP2146625B1 (en) | 2007-04-14 | 2019-08-14 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
US9204827B2 (en) | 2007-04-14 | 2015-12-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
US10111608B2 (en) | 2007-04-14 | 2018-10-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
CA2683930A1 (en) | 2007-04-14 | 2008-10-23 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
US20080269714A1 (en) | 2007-04-25 | 2008-10-30 | Medtronic Minimed, Inc. | Closed loop/semi-closed loop therapy modification system |
JP2010525881A (en) | 2007-04-27 | 2010-07-29 | エコー セラピューティクス, インコーポレイテッド | Skin permeation device for analyte detection or transdermal drug delivery |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10002233B2 (en) | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US7996158B2 (en) | 2007-05-14 | 2011-08-09 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US20200037875A1 (en) | 2007-05-18 | 2020-02-06 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
WO2008150917A1 (en) | 2007-05-31 | 2008-12-11 | Abbott Diabetes Care, Inc. | Insertion devices and methods |
EP2471457A1 (en) | 2007-06-07 | 2012-07-04 | Microchips, Inc. | Electrochemical biosensors and arrays |
US20080306434A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
EP3533387A3 (en) | 2007-06-21 | 2019-11-13 | Abbott Diabetes Care, Inc. | Health management devices and methods |
AU2008265542B2 (en) | 2007-06-21 | 2014-07-24 | Abbott Diabetes Care Inc. | Health monitor |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US7768386B2 (en) | 2007-07-31 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8834366B2 (en) | 2007-07-31 | 2014-09-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor calibration |
WO2009021052A1 (en) * | 2007-08-06 | 2009-02-12 | University Of Kentucky Research Foundation | Polypeptides, systems, and methods useful for detecting glucose |
US9968742B2 (en) | 2007-08-29 | 2018-05-15 | Medtronic Minimed, Inc. | Combined sensor and infusion set using separated sites |
US20120046533A1 (en) | 2007-08-29 | 2012-02-23 | Medtronic Minimed, Inc. | Combined sensor and infusion sets |
US9044178B2 (en) * | 2007-08-30 | 2015-06-02 | Pepex Biomedical, Llc | Electrochemical sensor and method for manufacturing |
US8702932B2 (en) | 2007-08-30 | 2014-04-22 | Pepex Biomedical, Inc. | Electrochemical sensor and method for manufacturing |
EP4159114B1 (en) | 2007-10-09 | 2024-04-10 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US8000918B2 (en) | 2007-10-23 | 2011-08-16 | Edwards Lifesciences Corporation | Monitoring and compensating for temperature-related error in an electrochemical sensor |
US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
US8409093B2 (en) | 2007-10-23 | 2013-04-02 | Abbott Diabetes Care Inc. | Assessing measures of glycemic variability |
US8216138B1 (en) | 2007-10-23 | 2012-07-10 | Abbott Diabetes Care Inc. | Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8512731B2 (en) * | 2007-11-13 | 2013-08-20 | Medtronic Minimed, Inc. | Antimicrobial coatings for medical devices and methods for making and using them |
US20090188811A1 (en) | 2007-11-28 | 2009-07-30 | Edwards Lifesciences Corporation | Preparation and maintenance of sensors |
US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
US8313467B2 (en) | 2007-12-27 | 2012-11-20 | Medtronic Minimed, Inc. | Reservoir pressure equalization systems and methods |
US10188787B2 (en) | 2007-12-31 | 2019-01-29 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
EP3679969A3 (en) | 2007-12-31 | 2020-09-30 | DEKA Products Limited Partnership | Infusion pump assembly |
US8900188B2 (en) | 2007-12-31 | 2014-12-02 | Deka Products Limited Partnership | Split ring resonator antenna adapted for use in wirelessly controlled medical device |
US9456955B2 (en) | 2007-12-31 | 2016-10-04 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
CN104874047B (en) | 2007-12-31 | 2019-05-28 | 德卡产品有限公司 | It is transfused pump assembly |
US8881774B2 (en) | 2007-12-31 | 2014-11-11 | Deka Research & Development Corp. | Apparatus, system and method for fluid delivery |
US10080704B2 (en) | 2007-12-31 | 2018-09-25 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
CA2715628A1 (en) | 2008-02-21 | 2009-08-27 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
JP5581310B2 (en) * | 2008-03-17 | 2014-08-27 | アイセンス コーポレーション | Analyte sensor subassembly |
US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
US8583204B2 (en) | 2008-03-28 | 2013-11-12 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8682408B2 (en) | 2008-03-28 | 2014-03-25 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
CA2721214A1 (en) | 2008-04-10 | 2009-10-15 | Abbott Diabetes Care Inc. | Method and system for sterilizing an analyte sensor |
US9295786B2 (en) | 2008-05-28 | 2016-03-29 | Medtronic Minimed, Inc. | Needle protective device for subcutaneous sensors |
US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US7826382B2 (en) | 2008-05-30 | 2010-11-02 | Abbott Diabetes Care Inc. | Close proximity communication device and methods |
US20100010328A1 (en) * | 2008-07-11 | 2010-01-14 | Nguyen Harry D | Probes and sensors for ascertaining blood characteristics and methods and devices for use therewith |
WO2010009172A1 (en) | 2008-07-14 | 2010-01-21 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
US8900431B2 (en) | 2008-08-27 | 2014-12-02 | Edwards Lifesciences Corporation | Analyte sensor |
US8622988B2 (en) | 2008-08-31 | 2014-01-07 | Abbott Diabetes Care Inc. | Variable rate closed loop control and methods |
US20100057040A1 (en) | 2008-08-31 | 2010-03-04 | Abbott Diabetes Care, Inc. | Robust Closed Loop Control And Methods |
US9943644B2 (en) | 2008-08-31 | 2018-04-17 | Abbott Diabetes Care Inc. | Closed loop control with reference measurement and methods thereof |
US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
US20100057046A1 (en) * | 2008-09-03 | 2010-03-04 | Keimar, Inc | Systems for characterizing physiologic parameters and methods for use therewith |
EP3881874A1 (en) | 2008-09-15 | 2021-09-22 | DEKA Products Limited Partnership | Systems and methods for fluid delivery |
US8560039B2 (en) | 2008-09-19 | 2013-10-15 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
US8986208B2 (en) | 2008-09-30 | 2015-03-24 | Abbott Diabetes Care Inc. | Analyte sensor sensitivity attenuation mitigation |
US8708376B2 (en) | 2008-10-10 | 2014-04-29 | Deka Products Limited Partnership | Medium connector |
US8223028B2 (en) | 2008-10-10 | 2012-07-17 | Deka Products Limited Partnership | Occlusion detection system and method |
US8016789B2 (en) | 2008-10-10 | 2011-09-13 | Deka Products Limited Partnership | Pump assembly with a removable cover assembly |
US8267892B2 (en) | 2008-10-10 | 2012-09-18 | Deka Products Limited Partnership | Multi-language / multi-processor infusion pump assembly |
US8066672B2 (en) | 2008-10-10 | 2011-11-29 | Deka Products Limited Partnership | Infusion pump assembly with a backup power supply |
US8262616B2 (en) | 2008-10-10 | 2012-09-11 | Deka Products Limited Partnership | Infusion pump assembly |
US9180245B2 (en) | 2008-10-10 | 2015-11-10 | Deka Products Limited Partnership | System and method for administering an infusible fluid |
US8208973B2 (en) | 2008-11-05 | 2012-06-26 | Medtronic Minimed, Inc. | System and method for variable beacon timing with wireless devices |
US9326707B2 (en) | 2008-11-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
US20110282172A1 (en) | 2008-11-11 | 2011-11-17 | Isense Corporation | Long-term implantable biosensor |
US8506740B2 (en) | 2008-11-14 | 2013-08-13 | Pepex Biomedical, Llc | Manufacturing electrochemical sensor module |
US9445755B2 (en) | 2008-11-14 | 2016-09-20 | Pepex Biomedical, Llc | Electrochemical sensor module |
US8951377B2 (en) | 2008-11-14 | 2015-02-10 | Pepex Biomedical, Inc. | Manufacturing electrochemical sensor module |
US20100160740A1 (en) * | 2008-12-24 | 2010-06-24 | Gary Cohen | Use of Patterns in a Therapy Management System |
US9330237B2 (en) * | 2008-12-24 | 2016-05-03 | Medtronic Minimed, Inc. | Pattern recognition and filtering in a therapy management system |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US20100198034A1 (en) | 2009-02-03 | 2010-08-05 | Abbott Diabetes Care Inc. | Compact On-Body Physiological Monitoring Devices and Methods Thereof |
US20100213057A1 (en) | 2009-02-26 | 2010-08-26 | Benjamin Feldman | Self-Powered Analyte Sensor |
US9446194B2 (en) | 2009-03-27 | 2016-09-20 | Dexcom, Inc. | Methods and systems for promoting glucose management |
US8497777B2 (en) | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
EP2419015A4 (en) | 2009-04-16 | 2014-08-20 | Abbott Diabetes Care Inc | Analyte sensor calibration management |
WO2010127050A1 (en) | 2009-04-28 | 2010-11-04 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
BRPI1010872A2 (en) * | 2009-04-29 | 2016-03-15 | Pharmacophotonics Inc | self-operating percutaneous optical sensor for intravascular fluid optical sensing |
WO2010127187A1 (en) | 2009-04-29 | 2010-11-04 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
EP2425209A4 (en) | 2009-04-29 | 2013-01-09 | Abbott Diabetes Care Inc | Method and system for providing real time analyte sensor calibration with retrospective backfill |
WO2010138856A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
JP2009207924A (en) * | 2009-06-23 | 2009-09-17 | Keimar Inc | Device and method for measuring cardiac output |
US8613892B2 (en) | 2009-06-30 | 2013-12-24 | Abbott Diabetes Care Inc. | Analyte meter with a moveable head and methods of using the same |
US10376213B2 (en) * | 2009-06-30 | 2019-08-13 | Waveform Technologies, Inc. | System, method and apparatus for sensor insertion |
US9351677B2 (en) | 2009-07-02 | 2016-05-31 | Dexcom, Inc. | Analyte sensor with increased reference capacity |
US20110027458A1 (en) * | 2009-07-02 | 2011-02-03 | Dexcom, Inc. | Continuous analyte sensors and methods of making same |
US8344847B2 (en) | 2009-07-09 | 2013-01-01 | Medtronic Minimed, Inc. | Coordination of control commands in a medical device system having at least one therapy delivery device and at least one wireless controller device |
CA2768011C (en) | 2009-07-15 | 2018-07-24 | Deka Products Limited Partnership | Apparatus, systems and methods for an infusion pump assembly |
DK3689237T3 (en) | 2009-07-23 | 2021-08-16 | Abbott Diabetes Care Inc | Method of preparation and system for continuous analyte measurement |
WO2011014851A1 (en) | 2009-07-31 | 2011-02-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
ES2959131T3 (en) | 2009-08-31 | 2024-02-20 | Abbott Diabetes Care Inc | Displays for a medical device |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
EP3001194B1 (en) | 2009-08-31 | 2019-04-17 | Abbott Diabetes Care, Inc. | Medical devices and methods |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US8487758B2 (en) | 2009-09-02 | 2013-07-16 | Medtronic Minimed, Inc. | Medical device having an intelligent alerting scheme, and related operating methods |
US9320461B2 (en) | 2009-09-29 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
EP2482724A2 (en) | 2009-09-30 | 2012-08-08 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20110082356A1 (en) | 2009-10-01 | 2011-04-07 | Medtronic Minimed, Inc. | Analyte sensor apparatuses having interference rejection membranes and methods for making and using them |
WO2011053881A1 (en) | 2009-10-30 | 2011-05-05 | Abbott Diabetes Care Inc. | Method and apparatus for detecting false hypoglycemic conditions |
US8386042B2 (en) | 2009-11-03 | 2013-02-26 | Medtronic Minimed, Inc. | Omnidirectional accelerometer device and medical device incorporating same |
US8660628B2 (en) * | 2009-12-21 | 2014-02-25 | Medtronic Minimed, Inc. | Analyte sensors comprising blended membrane compositions and methods for making and using them |
US8574201B2 (en) | 2009-12-22 | 2013-11-05 | Medtronic Minimed, Inc. | Syringe piston with check valve seal |
US8755269B2 (en) | 2009-12-23 | 2014-06-17 | Medtronic Minimed, Inc. | Ranking and switching of wireless channels in a body area network of medical devices |
JP5844280B2 (en) | 2010-01-22 | 2016-01-13 | デカ・プロダクツ・リミテッド・パートナーシップ | Method and system for shape memory alloy wire control |
USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
WO2011112753A1 (en) | 2010-03-10 | 2011-09-15 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
US10448872B2 (en) | 2010-03-16 | 2019-10-22 | Medtronic Minimed, Inc. | Analyte sensor apparatuses having improved electrode configurations and methods for making and using them |
CN102639185B (en) | 2010-03-24 | 2015-02-04 | 雅培糖尿病护理公司 | Medical device inserters and processes of inserting and using medical devices |
US8636711B2 (en) | 2010-06-14 | 2014-01-28 | Legacy Emanuel Hospital & Health Center | Stabilized glucagon solutions and uses therefor |
US8635046B2 (en) | 2010-06-23 | 2014-01-21 | Abbott Diabetes Care Inc. | Method and system for evaluating analyte sensor response characteristics |
US9215995B2 (en) | 2010-06-23 | 2015-12-22 | Medtronic Minimed, Inc. | Sensor systems having multiple probes and electrode arrays |
US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
US11213226B2 (en) | 2010-10-07 | 2022-01-04 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods |
US8562565B2 (en) | 2010-10-15 | 2013-10-22 | Medtronic Minimed, Inc. | Battery shock absorber for a portable medical device |
US8603033B2 (en) | 2010-10-15 | 2013-12-10 | Medtronic Minimed, Inc. | Medical device and related assembly having an offset element for a piezoelectric speaker |
US8603032B2 (en) | 2010-10-15 | 2013-12-10 | Medtronic Minimed, Inc. | Medical device with membrane keypad sealing element, and related manufacturing method |
US8479595B2 (en) | 2010-10-20 | 2013-07-09 | Medtronic Minimed, Inc. | Sensor assembly and medical device incorporating same |
US8495918B2 (en) | 2010-10-20 | 2013-07-30 | Medtronic Minimed, Inc. | Sensor assembly and medical device incorporating same |
US8474332B2 (en) | 2010-10-20 | 2013-07-02 | Medtronic Minimed, Inc. | Sensor assembly and medical device incorporating same |
US8197444B1 (en) | 2010-12-22 | 2012-06-12 | Medtronic Minimed, Inc. | Monitoring the seating status of a fluid reservoir in a fluid infusion device |
US8628510B2 (en) | 2010-12-22 | 2014-01-14 | Medtronic Minimed, Inc. | Monitoring the operating health of a force sensor in a fluid infusion device |
US8690855B2 (en) | 2010-12-22 | 2014-04-08 | Medtronic Minimed, Inc. | Fluid reservoir seating procedure for a fluid infusion device |
US8469942B2 (en) | 2010-12-22 | 2013-06-25 | Medtronic Minimed, Inc. | Occlusion detection for a fluid infusion device |
US9393399B2 (en) | 2011-02-22 | 2016-07-19 | Medtronic Minimed, Inc. | Sealing assembly for a fluid reservoir of a fluid infusion device |
US9283318B2 (en) | 2011-02-22 | 2016-03-15 | Medtronic Minimed, Inc. | Flanged sealing element and needle guide pin assembly for a fluid infusion device having a needled fluid reservoir |
US9463309B2 (en) | 2011-02-22 | 2016-10-11 | Medtronic Minimed, Inc. | Sealing assembly and structure for a fluid infusion device having a needled fluid reservoir |
US8870829B2 (en) | 2011-02-22 | 2014-10-28 | Medtronic Minimed, Inc. | Fluid infusion device and related sealing assembly for a needleless fluid reservoir |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US8614596B2 (en) | 2011-02-28 | 2013-12-24 | Medtronic Minimed, Inc. | Systems and methods for initializing a voltage bus and medical devices incorporating same |
CN107019515B (en) | 2011-02-28 | 2021-02-26 | 雅培糖尿病护理公司 | Method of displaying sensor readings and analyte monitoring device and method of operating the same |
US9101305B2 (en) | 2011-03-09 | 2015-08-11 | Medtronic Minimed, Inc. | Glucose sensor product and related manufacturing and packaging methods |
US8564447B2 (en) | 2011-03-18 | 2013-10-22 | Medtronic Minimed, Inc. | Battery life indication techniques for an electronic device |
US9018893B2 (en) | 2011-03-18 | 2015-04-28 | Medtronic Minimed, Inc. | Power control techniques for an electronic device |
WO2012142502A2 (en) | 2011-04-15 | 2012-10-18 | Dexcom Inc. | Advanced analyte sensor calibration and error detection |
US9008744B2 (en) | 2011-05-06 | 2015-04-14 | Medtronic Minimed, Inc. | Method and apparatus for continuous analyte monitoring |
WO2012159040A2 (en) | 2011-05-19 | 2012-11-22 | Pepex Biomedical Inc. | Fluid management and patient monitoring system |
WO2012162151A2 (en) | 2011-05-20 | 2012-11-29 | Pepex Biomedical, Inc. | Manufacturing electrochemical sensor modules |
WO2013066849A1 (en) | 2011-10-31 | 2013-05-10 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
US9069536B2 (en) | 2011-10-31 | 2015-06-30 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
AU2012335830B2 (en) | 2011-11-07 | 2017-05-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US8710993B2 (en) | 2011-11-23 | 2014-04-29 | Abbott Diabetes Care Inc. | Mitigating single point failure of devices in an analyte monitoring system and methods thereof |
US9317656B2 (en) | 2011-11-23 | 2016-04-19 | Abbott Diabetes Care Inc. | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof |
WO2013078426A2 (en) | 2011-11-25 | 2013-05-30 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
EP4344633A2 (en) | 2011-12-11 | 2024-04-03 | Abbott Diabetes Care, Inc. | Analyte sensor methods |
US9610401B2 (en) | 2012-01-13 | 2017-04-04 | Medtronic Minimed, Inc. | Infusion set component with modular fluid channel element |
WO2013134519A2 (en) | 2012-03-07 | 2013-09-12 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
CA2806765C (en) | 2012-03-08 | 2020-09-22 | Isense Corporation | Method and apparatus for insertion of a sensor |
WO2013138275A1 (en) | 2012-03-12 | 2013-09-19 | University Of South Florida | Implantable biocompatible sic sensors |
US8523803B1 (en) | 2012-03-20 | 2013-09-03 | Medtronic Minimed, Inc. | Motor health monitoring and medical device incorporating same |
US8603026B2 (en) | 2012-03-20 | 2013-12-10 | Medtronic Minimed, Inc. | Dynamic pulse-width modulation motor control and medical device incorporating same |
US8603027B2 (en) | 2012-03-20 | 2013-12-10 | Medtronic Minimed, Inc. | Occlusion detection using pulse-width modulation and medical device incorporating same |
US10391242B2 (en) | 2012-06-07 | 2019-08-27 | Medtronic Minimed, Inc. | Diabetes therapy management system for recommending bolus calculator adjustments |
US9333292B2 (en) | 2012-06-26 | 2016-05-10 | Medtronic Minimed, Inc. | Mechanically actuated fluid infusion device |
US20140012115A1 (en) | 2012-07-03 | 2014-01-09 | Medtronic Minimed, Inc. | Plasma deposited adhesion promoter layers for use with analyte sensors |
US8808269B2 (en) | 2012-08-21 | 2014-08-19 | Medtronic Minimed, Inc. | Reservoir plunger position monitoring and medical device incorporating same |
US9878096B2 (en) | 2012-08-30 | 2018-01-30 | Medtronic Minimed, Inc. | Generation of target glucose values for a closed-loop operating mode of an insulin infusion system |
US20140066884A1 (en) | 2012-08-30 | 2014-03-06 | Medtronic Minimed, Inc. | Sensor model supervisor for a closed-loop insulin infusion system |
EP3395252A1 (en) | 2012-08-30 | 2018-10-31 | Abbott Diabetes Care, Inc. | Dropout detection in continuous analyte monitoring data during data excursions |
US10130767B2 (en) | 2012-08-30 | 2018-11-20 | Medtronic Minimed, Inc. | Sensor model supervisor for a closed-loop insulin infusion system |
US9662445B2 (en) | 2012-08-30 | 2017-05-30 | Medtronic Minimed, Inc. | Regulating entry into a closed-loop operating mode of an insulin infusion system |
US10496797B2 (en) | 2012-08-30 | 2019-12-03 | Medtronic Minimed, Inc. | Blood glucose validation for a closed-loop operating mode of an insulin infusion system |
US9849239B2 (en) | 2012-08-30 | 2017-12-26 | Medtronic Minimed, Inc. | Generation and application of an insulin limit for a closed-loop operating mode of an insulin infusion system |
US9623179B2 (en) | 2012-08-30 | 2017-04-18 | Medtronic Minimed, Inc. | Safeguarding techniques for a closed-loop insulin infusion system |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
EP2901153A4 (en) | 2012-09-26 | 2016-04-27 | Abbott Diabetes Care Inc | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US8870818B2 (en) | 2012-11-15 | 2014-10-28 | Medtronic Minimed, Inc. | Systems and methods for alignment and detection of a consumable component |
CN104918551B (en) | 2012-12-03 | 2019-07-26 | Pepex生物医药有限公司 | Sensor module and the method for using sensor module |
US9107994B2 (en) | 2013-01-18 | 2015-08-18 | Medtronic Minimed, Inc. | Systems for fluid reservoir retention |
US9522223B2 (en) | 2013-01-18 | 2016-12-20 | Medtronic Minimed, Inc. | Systems for fluid reservoir retention |
US9033924B2 (en) | 2013-01-18 | 2015-05-19 | Medtronic Minimed, Inc. | Systems for fluid reservoir retention |
US9308321B2 (en) | 2013-02-18 | 2016-04-12 | Medtronic Minimed, Inc. | Infusion device having gear assembly initialization |
US10130288B2 (en) | 2013-03-14 | 2018-11-20 | Cell and Molecular Tissue Engineering, LLC | Coated sensors, and corresponding systems and methods |
US10405961B2 (en) | 2013-03-14 | 2019-09-10 | Cell and Molecular Tissue Engineering, LLC | Coated surgical mesh, and corresponding systems and methods |
WO2014152034A1 (en) | 2013-03-15 | 2014-09-25 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
US9474475B1 (en) | 2013-03-15 | 2016-10-25 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
US10433773B1 (en) | 2013-03-15 | 2019-10-08 | Abbott Diabetes Care Inc. | Noise rejection methods and apparatus for sparsely sampled analyte sensor data |
US8920381B2 (en) | 2013-04-12 | 2014-12-30 | Medtronic Minimed, Inc. | Infusion set with improved bore configuration |
EP4309699A3 (en) | 2013-07-03 | 2024-04-24 | DEKA Products Limited Partnership | Apparatus and system for fluid delivery |
US9433731B2 (en) | 2013-07-19 | 2016-09-06 | Medtronic Minimed, Inc. | Detecting unintentional motor motion and infusion device incorporating same |
US9402949B2 (en) | 2013-08-13 | 2016-08-02 | Medtronic Minimed, Inc. | Detecting conditions associated with medical device operations using matched filters |
US9880528B2 (en) | 2013-08-21 | 2018-01-30 | Medtronic Minimed, Inc. | Medical devices and related updating methods and systems |
US9889257B2 (en) | 2013-08-21 | 2018-02-13 | Medtronic Minimed, Inc. | Systems and methods for updating medical devices |
US9259528B2 (en) | 2013-08-22 | 2016-02-16 | Medtronic Minimed, Inc. | Fluid infusion device with safety coupling |
US9750878B2 (en) | 2013-12-11 | 2017-09-05 | Medtronic Minimed, Inc. | Closed-loop control of glucose according to a predicted blood glucose trajectory |
US9750877B2 (en) | 2013-12-11 | 2017-09-05 | Medtronic Minimed, Inc. | Predicted time to assess and/or control a glycemic state |
US9849240B2 (en) | 2013-12-12 | 2017-12-26 | Medtronic Minimed, Inc. | Data modification for predictive operations and devices incorporating same |
US10105488B2 (en) | 2013-12-12 | 2018-10-23 | Medtronic Minimed, Inc. | Predictive infusion device operations and related methods and systems |
US9694132B2 (en) | 2013-12-19 | 2017-07-04 | Medtronic Minimed, Inc. | Insertion device for insertion set |
WO2015102745A1 (en) | 2013-12-31 | 2015-07-09 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
US9861748B2 (en) | 2014-02-06 | 2018-01-09 | Medtronic Minimed, Inc. | User-configurable closed-loop notifications and infusion systems incorporating same |
US9399096B2 (en) | 2014-02-06 | 2016-07-26 | Medtronic Minimed, Inc. | Automatic closed-loop control adjustments and infusion systems incorporating same |
US9987422B2 (en) | 2014-03-24 | 2018-06-05 | Medtronic Minimed, Inc. | Fluid infusion patch pump device with automatic startup feature |
EP3125761B1 (en) | 2014-03-30 | 2020-09-30 | Abbott Diabetes Care Inc. | Method and apparatus for determining meal start and peak events in analyte monitoring systems |
US10001450B2 (en) | 2014-04-18 | 2018-06-19 | Medtronic Minimed, Inc. | Nonlinear mapping technique for a physiological characteristic sensor |
US10232113B2 (en) | 2014-04-24 | 2019-03-19 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for regulating insulin on board |
US9681828B2 (en) | 2014-05-01 | 2017-06-20 | Medtronic Minimed, Inc. | Physiological characteristic sensors and methods for forming such sensors |
US10275572B2 (en) | 2014-05-01 | 2019-04-30 | Medtronic Minimed, Inc. | Detecting blockage of a reservoir cavity during a seating operation of a fluid infusion device |
US10274349B2 (en) | 2014-05-19 | 2019-04-30 | Medtronic Minimed, Inc. | Calibration factor adjustments for infusion devices and related methods and systems |
US10152049B2 (en) | 2014-05-19 | 2018-12-11 | Medtronic Minimed, Inc. | Glucose sensor health monitoring and related methods and systems |
US10007765B2 (en) | 2014-05-19 | 2018-06-26 | Medtronic Minimed, Inc. | Adaptive signal processing for infusion devices and related methods and systems |
EP3152559B1 (en) | 2014-06-04 | 2020-12-02 | Pepex Biomedical, Inc. | Electrochemical sensors made using advanced printing technology |
JP6170882B2 (en) * | 2014-06-20 | 2017-07-26 | 本田技研工業株式会社 | Hydrogen peroxide concentration detection sensor for fuel cell and hydrogen peroxide concentration detection sensor |
US9833563B2 (en) | 2014-09-26 | 2017-12-05 | Medtronic Minimed, Inc. | Systems for managing reservoir chamber pressure |
US9839753B2 (en) | 2014-09-26 | 2017-12-12 | Medtronic Minimed, Inc. | Systems for managing reservoir chamber pressure |
US10279126B2 (en) | 2014-10-07 | 2019-05-07 | Medtronic Minimed, Inc. | Fluid conduit assembly with gas trapping filter in the fluid flow path |
US10598624B2 (en) | 2014-10-23 | 2020-03-24 | Abbott Diabetes Care Inc. | Electrodes having at least one sensing structure and methods for making and using the same |
US9833564B2 (en) | 2014-11-25 | 2017-12-05 | Medtronic Minimed, Inc. | Fluid conduit assembly with air venting features |
US10195341B2 (en) | 2014-11-26 | 2019-02-05 | Medtronic Minimed, Inc. | Systems and methods for fluid infusion device with automatic reservoir fill |
US9987420B2 (en) | 2014-11-26 | 2018-06-05 | Medtronic Minimed, Inc. | Systems and methods for fluid infusion device with automatic reservoir fill |
US9636453B2 (en) | 2014-12-04 | 2017-05-02 | Medtronic Minimed, Inc. | Advance diagnosis of infusion device operating mode viability |
US9943645B2 (en) | 2014-12-04 | 2018-04-17 | Medtronic Minimed, Inc. | Methods for operating mode transitions and related infusion devices and systems |
US9937292B2 (en) | 2014-12-09 | 2018-04-10 | Medtronic Minimed, Inc. | Systems for filling a fluid infusion device reservoir |
US10265031B2 (en) | 2014-12-19 | 2019-04-23 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for automatic alert clearing |
US10307535B2 (en) | 2014-12-19 | 2019-06-04 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for preemptive alerting |
US10251605B2 (en) | 2015-02-16 | 2019-04-09 | Verily Life Sciences Llc | Bandage type of continuous glucose monitoring system |
JP2018510672A (en) * | 2015-02-16 | 2018-04-19 | ヴェリリー ライフ サイエンシズ エルエルシー | Electrochemical sensor for bandage type continuous glucose monitoring system |
US10307528B2 (en) | 2015-03-09 | 2019-06-04 | Medtronic Minimed, Inc. | Extensible infusion devices and related methods |
US10449298B2 (en) | 2015-03-26 | 2019-10-22 | Medtronic Minimed, Inc. | Fluid injection devices and related methods |
US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
WO2016183493A1 (en) | 2015-05-14 | 2016-11-17 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
US10137243B2 (en) | 2015-05-26 | 2018-11-27 | Medtronic Minimed, Inc. | Infusion devices with distributed motor control and related operating methods |
GB2538724A (en) * | 2015-05-26 | 2016-11-30 | Imp Innovations Ltd | Methods |
US9999721B2 (en) | 2015-05-26 | 2018-06-19 | Medtronic Minimed, Inc. | Error handling in infusion devices with distributed motor control and related operating methods |
US10575767B2 (en) | 2015-05-29 | 2020-03-03 | Medtronic Minimed, Inc. | Method for monitoring an analyte, analyte sensor and analyte monitoring apparatus |
US10780222B2 (en) | 2015-06-03 | 2020-09-22 | Pacific Diabetes Technologies Inc | Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives |
US9879668B2 (en) | 2015-06-22 | 2018-01-30 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and an optical sensor |
US9987425B2 (en) | 2015-06-22 | 2018-06-05 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and sensor contact elements |
US9878095B2 (en) | 2015-06-22 | 2018-01-30 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and multiple sensor contact elements |
US10010668B2 (en) | 2015-06-22 | 2018-07-03 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and a force sensor |
US9993594B2 (en) | 2015-06-22 | 2018-06-12 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and rotor position sensors |
CN108024765B (en) | 2015-07-10 | 2021-06-11 | 雅培糖尿病护理公司 | System, device and method for dynamic glucose curve response to physiological parameters |
US10463297B2 (en) | 2015-08-21 | 2019-11-05 | Medtronic Minimed, Inc. | Personalized event detection methods and related devices and systems |
US10201657B2 (en) | 2015-08-21 | 2019-02-12 | Medtronic Minimed, Inc. | Methods for providing sensor site rotation feedback and related infusion devices and systems |
US10293108B2 (en) | 2015-08-21 | 2019-05-21 | Medtronic Minimed, Inc. | Infusion devices and related patient ratio adjustment methods |
US10478557B2 (en) | 2015-08-21 | 2019-11-19 | Medtronic Minimed, Inc. | Personalized parameter modeling methods and related devices and systems |
US20170053552A1 (en) | 2015-08-21 | 2017-02-23 | Medtronic Minimed, Inc. | Management and prioritization of the delivery of glycemic insight messages |
US10117992B2 (en) | 2015-09-29 | 2018-11-06 | Medtronic Minimed, Inc. | Infusion devices and related rescue detection methods |
CN112932477A (en) * | 2015-10-19 | 2021-06-11 | 中国农业大学 | Blood glucose sensor implanted in interocular scleral interstitial fluid of live fish eyeball and preparation method thereof |
US11666702B2 (en) | 2015-10-19 | 2023-06-06 | Medtronic Minimed, Inc. | Medical devices and related event pattern treatment recommendation methods |
US11501867B2 (en) | 2015-10-19 | 2022-11-15 | Medtronic Minimed, Inc. | Medical devices and related event pattern presentation methods |
US10146911B2 (en) | 2015-10-23 | 2018-12-04 | Medtronic Minimed, Inc. | Medical devices and related methods and systems for data transfer |
US10037722B2 (en) | 2015-11-03 | 2018-07-31 | Medtronic Minimed, Inc. | Detecting breakage in a display element |
CN105445345B (en) * | 2015-11-12 | 2018-06-05 | 三诺生物传感股份有限公司 | A kind of preparation method of flexibility implant electrode |
US10449306B2 (en) | 2015-11-25 | 2019-10-22 | Medtronics Minimed, Inc. | Systems for fluid delivery with wicking membrane |
US10589038B2 (en) | 2016-04-27 | 2020-03-17 | Medtronic Minimed, Inc. | Set connector systems for venting a fluid reservoir |
EP3449827B1 (en) | 2016-04-27 | 2020-05-13 | PHC Holdings Corporation | Sensor insertion device |
US10324058B2 (en) | 2016-04-28 | 2019-06-18 | Medtronic Minimed, Inc. | In-situ chemistry stack for continuous glucose sensors |
WO2017195035A1 (en) | 2016-05-10 | 2017-11-16 | Interface Biologics, Inc. | Implantable glucose sensors having a biostable surface |
US11179078B2 (en) | 2016-06-06 | 2021-11-23 | Medtronic Minimed, Inc. | Polycarbonate urea/urethane polymers for use with analyte sensors |
US11097051B2 (en) | 2016-11-04 | 2021-08-24 | Medtronic Minimed, Inc. | Methods and apparatus for detecting and reacting to insufficient hypoglycemia response |
US10238030B2 (en) | 2016-12-06 | 2019-03-26 | Medtronic Minimed, Inc. | Wireless medical device with a complementary split ring resonator arrangement for suppression of electromagnetic interference |
US10272201B2 (en) | 2016-12-22 | 2019-04-30 | Medtronic Minimed, Inc. | Insertion site monitoring methods and related infusion devices and systems |
CN110461217B (en) | 2017-01-23 | 2022-09-16 | 雅培糖尿病护理公司 | Systems, devices, and methods for analyte sensor insertion |
US10500135B2 (en) | 2017-01-30 | 2019-12-10 | Medtronic Minimed, Inc. | Fluid reservoir and systems for filling a fluid reservoir of a fluid infusion device |
US10532165B2 (en) | 2017-01-30 | 2020-01-14 | Medtronic Minimed, Inc. | Fluid reservoir and systems for filling a fluid reservoir of a fluid infusion device |
US10363365B2 (en) | 2017-02-07 | 2019-07-30 | Medtronic Minimed, Inc. | Infusion devices and related consumable calibration methods |
US10552580B2 (en) | 2017-02-07 | 2020-02-04 | Medtronic Minimed, Inc. | Infusion system consumables and related calibration methods |
US11207463B2 (en) | 2017-02-21 | 2021-12-28 | Medtronic Minimed, Inc. | Apparatuses, systems, and methods for identifying an infusate in a reservoir of an infusion device |
US10646649B2 (en) | 2017-02-21 | 2020-05-12 | Medtronic Minimed, Inc. | Infusion devices and fluid identification apparatuses and methods |
WO2018175489A1 (en) | 2017-03-21 | 2018-09-27 | Abbott Diabetes Care Inc. | Methods, devices and system for providing diabetic condition diagnosis and therapy |
EP3619531A4 (en) * | 2017-05-04 | 2020-05-06 | Siemens Healthcare Diagnostics Inc. | Biosensors produced from enzymes with reduced solubility and methods of production and use thereof |
JP7157055B2 (en) * | 2017-07-05 | 2022-10-19 | テルモ株式会社 | SENSOR AND SENSOR MANUFACTURING METHOD |
JP7136776B2 (en) | 2017-07-05 | 2022-09-13 | テルモ株式会社 | Method for manufacturing sensor and needle member of sensor |
CN212438615U (en) | 2017-10-24 | 2021-02-02 | 德克斯康公司 | Wearable device |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
AU2019218260B2 (en) | 2018-02-09 | 2022-01-06 | W. L. Gore & Associates, Inc. | Implantable access chamber and associated methods of use |
EP3784312A1 (en) | 2018-04-24 | 2021-03-03 | DEKA Products Limited Partnership | Apparatus and system for fluid delivery |
WO2019222499A1 (en) | 2018-05-16 | 2019-11-21 | Medtronic Minimed, Inc. | Thermally stable glucose limiting membrane for glucose sensors |
WO2020117788A1 (en) * | 2018-12-03 | 2020-06-11 | Laxml Therapeutic Devices, Inc. | Needles for measurement of body fluid analytes such as glucose |
USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
US20220240823A1 (en) | 2021-01-29 | 2022-08-04 | Medtronic Minimed, Inc. | Interference rejection membranes useful with analyte sensors |
US20220338768A1 (en) | 2021-04-09 | 2022-10-27 | Medtronic Minimed, Inc. | Hexamethyldisiloxane membranes for analyte sensors |
US20230113175A1 (en) | 2021-10-08 | 2023-04-13 | Medtronic Minimed, Inc. | Immunosuppressant releasing coatings |
US20240023849A1 (en) | 2022-07-20 | 2024-01-25 | Medtronic Minimed, Inc. | Acrylate hydrogel membrane for dual function of diffusion limiting membrane as well as attenuation to the foreign body response |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3249103A (en) * | 1963-01-21 | 1966-05-03 | Charles F Woodhouse | Method and apparatus for measuring bioelectronic parameters |
US3726777A (en) * | 1970-04-30 | 1973-04-10 | Gen Electric | Iridium-iridium oxide electrode for measuring ph of blood and other fluids |
JPS5627643A (en) * | 1979-08-14 | 1981-03-18 | Toshiba Corp | Electrochemical measuring device |
JPS57169668A (en) * | 1981-04-10 | 1982-10-19 | Fujisawa Pharmaceut Co Ltd | Electrode for measuring glucose concentration |
DE3278334D1 (en) * | 1981-10-23 | 1988-05-19 | Genetics Int Inc | Sensor for components of a liquid mixture |
SU1296913A1 (en) * | 1984-03-19 | 1987-03-15 | Казанский государственный университет им.В.И.Ульянова-Ленина | Ferment electrode for determining concentrations of thiocholine ethers |
US4671288A (en) * | 1985-06-13 | 1987-06-09 | The Regents Of The University Of California | Electrochemical cell sensor for continuous short-term use in tissues and blood |
JPS62261341A (en) * | 1986-05-07 | 1987-11-13 | 新技術開発事業団 | Internal stay type sensor for measuring level of glucose |
JPS62274254A (en) * | 1986-05-23 | 1987-11-28 | Res Dev Corp Of Japan | Sensor for measuring bio-component |
NL8702370A (en) * | 1987-10-05 | 1989-05-01 | Groningen Science Park | METHOD AND SYSTEM FOR GLUCOSE DETERMINATION AND USEABLE MEASURING CELL ASSEMBLY. |
GB8725936D0 (en) * | 1987-11-05 | 1987-12-09 | Genetics Int Inc | Sensing system |
JPH0633644A (en) * | 1992-07-10 | 1994-02-08 | Showa Lock Kk | Controlling device for presence-absence in room |
-
1991
- 1991-04-09 US US07/682,560 patent/US5165407A/en not_active Expired - Lifetime
- 1991-04-17 AT AT91919026T patent/ATE194062T1/en not_active IP Right Cessation
- 1991-04-17 JP JP50863891A patent/JP3194434B2/en not_active Expired - Fee Related
- 1991-04-17 AU AU77828/91A patent/AU640785B2/en not_active Ceased
- 1991-04-17 DE DE69132270T patent/DE69132270T2/en not_active Expired - Fee Related
- 1991-04-17 WO PCT/US1991/002641 patent/WO1991015993A1/en active IP Right Grant
- 1991-04-17 ES ES91919026T patent/ES2148154T3/en not_active Expired - Lifetime
- 1991-04-17 DK DK91919026T patent/DK0525127T3/en active
- 1991-04-17 CA CA002080022A patent/CA2080022C/en not_active Expired - Fee Related
- 1991-04-17 EP EP91919026A patent/EP0525127B1/en not_active Expired - Lifetime
-
2000
- 2000-09-08 GR GR20000402063T patent/GR3034376T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0525127A1 (en) | 1993-02-03 |
AU7782891A (en) | 1991-11-11 |
DE69132270T2 (en) | 2000-10-26 |
GR3034376T3 (en) | 2000-12-29 |
WO1991015993A1 (en) | 1991-10-31 |
DE69132270D1 (en) | 2000-08-03 |
EP0525127A4 (en) | 1996-07-10 |
CA2080022A1 (en) | 1991-10-20 |
ATE194062T1 (en) | 2000-07-15 |
DK0525127T3 (en) | 2000-08-28 |
JP3194434B2 (en) | 2001-07-30 |
ES2148154T3 (en) | 2000-10-16 |
JPH05506172A (en) | 1993-09-16 |
EP0525127B1 (en) | 2000-06-28 |
AU640785B2 (en) | 1993-09-02 |
US5165407A (en) | 1992-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2080022C (en) | Implantable glucose sensor | |
US10327678B2 (en) | Analyte sensor apparatuses comprising multiple implantable sensor elements and methods for making and using them | |
CA2789814C (en) | Analyte sensor apparatuses having improved electrode configurations and methods for making and using them | |
CA2731816C (en) | Analyte sensor apparatuses having improved electrode configurations and methods for making and using them | |
JP5688971B2 (en) | Combination of sensor and infusion set using separation sites | |
US9237865B2 (en) | Analyte sensors and methods for making and using them | |
CA2648151C (en) | Methods and materials for controlling the electrochemistry of analyte sensors | |
US7153265B2 (en) | Anti-inflammatory biosensor for reduced biofouling and enhanced sensor performance | |
US20150122647A1 (en) | Enzyme matrices for use with ethylene oxide sterilization | |
JPS6272322A (en) | Electrochemical battery sensor for continuous/short-term usein tissue and blood | |
US11638545B2 (en) | Reducing sensor foreign body response via high surface area metal structures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |